| 3.6 |
21.7 |
GO:0002803 |
positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antibacterial peptide production(GO:0002803) |
| 3.0 |
9.1 |
GO:0048817 |
negative regulation of hair follicle maturation(GO:0048817) |
| 2.7 |
10.8 |
GO:0032600 |
B cell receptor transport within lipid bilayer(GO:0032595) B cell receptor transport into membrane raft(GO:0032597) protein transport out of membrane raft(GO:0032599) chemokine receptor transport out of membrane raft(GO:0032600) negative regulation of transforming growth factor beta3 production(GO:0032913) chemokine receptor transport within lipid bilayer(GO:0033606) |
| 2.7 |
8.0 |
GO:2000309 |
positive regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000309) |
| 2.2 |
13.2 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 2.0 |
8.1 |
GO:1903575 |
cornified envelope assembly(GO:1903575) |
| 2.0 |
8.0 |
GO:0042377 |
menaquinone catabolic process(GO:0042361) vitamin K catabolic process(GO:0042377) |
| 1.9 |
9.7 |
GO:0097021 |
lymphocyte migration into lymphoid organs(GO:0097021) |
| 1.8 |
7.0 |
GO:0060448 |
dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
| 1.7 |
1.7 |
GO:0032912 |
negative regulation of transforming growth factor beta2 production(GO:0032912) |
| 1.5 |
6.1 |
GO:0050712 |
negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
| 1.4 |
19.7 |
GO:0031642 |
negative regulation of myelination(GO:0031642) |
| 1.4 |
1.4 |
GO:0009233 |
menaquinone metabolic process(GO:0009233) |
| 1.3 |
4.0 |
GO:0060086 |
circadian temperature homeostasis(GO:0060086) |
| 1.3 |
16.9 |
GO:0038129 |
ERBB3 signaling pathway(GO:0038129) |
| 1.3 |
5.2 |
GO:0048627 |
myoblast development(GO:0048627) |
| 1.2 |
3.5 |
GO:1904806 |
regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
| 1.2 |
5.8 |
GO:0098904 |
regulation of AV node cell action potential(GO:0098904) |
| 1.1 |
3.4 |
GO:0015920 |
lipopolysaccharide transport(GO:0015920) |
| 1.1 |
4.5 |
GO:0060672 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 1.1 |
3.2 |
GO:0046967 |
cytosol to ER transport(GO:0046967) |
| 1.1 |
3.2 |
GO:0032289 |
central nervous system myelin formation(GO:0032289) |
| 1.1 |
6.5 |
GO:0003011 |
involuntary skeletal muscle contraction(GO:0003011) |
| 1.1 |
4.3 |
GO:0021827 |
cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) chemorepulsion involved in postnatal olfactory bulb interneuron migration(GO:0021836) |
| 1.0 |
4.2 |
GO:2000053 |
regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) |
| 1.0 |
1.0 |
GO:1901526 |
positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
| 1.0 |
2.1 |
GO:0002585 |
positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 1.0 |
3.0 |
GO:1903348 |
positive regulation of bicellular tight junction assembly(GO:1903348) |
| 1.0 |
12.0 |
GO:0015820 |
leucine transport(GO:0015820) |
| 1.0 |
3.0 |
GO:0043000 |
Golgi to plasma membrane CFTR protein transport(GO:0043000) |
| 1.0 |
8.9 |
GO:0031444 |
slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 1.0 |
5.9 |
GO:0089712 |
L-aspartate transport(GO:0070778) L-aspartate transmembrane transport(GO:0089712) |
| 1.0 |
5.8 |
GO:0035604 |
fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) |
| 1.0 |
5.8 |
GO:2001181 |
positive regulation of interleukin-10 secretion(GO:2001181) |
| 1.0 |
4.9 |
GO:1904398 |
positive regulation of neuromuscular junction development(GO:1904398) |
| 1.0 |
6.8 |
GO:0015888 |
thiamine transport(GO:0015888) |
| 1.0 |
10.6 |
GO:0019367 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 1.0 |
4.8 |
GO:0010986 |
positive regulation of lipoprotein particle clearance(GO:0010986) |
| 1.0 |
2.9 |
GO:0090038 |
negative regulation of protein kinase C signaling(GO:0090038) |
| 0.9 |
15.1 |
GO:0070444 |
oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 0.9 |
3.7 |
GO:1990834 |
response to odorant(GO:1990834) |
| 0.9 |
3.7 |
GO:0003130 |
BMP signaling pathway involved in heart induction(GO:0003130) endodermal-mesodermal cell signaling(GO:0003133) endodermal-mesodermal cell signaling involved in heart induction(GO:0003134) |
| 0.9 |
2.8 |
GO:1990764 |
regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
| 0.9 |
4.6 |
GO:2000721 |
positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
| 0.9 |
1.8 |
GO:1903937 |
response to acrylamide(GO:1903937) |
| 0.9 |
6.4 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.9 |
2.7 |
GO:0003245 |
cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
| 0.9 |
4.5 |
GO:0015862 |
uridine transport(GO:0015862) |
| 0.9 |
2.7 |
GO:0001796 |
type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) |
| 0.9 |
24.7 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.9 |
3.5 |
GO:0071072 |
negative regulation of phospholipid biosynthetic process(GO:0071072) |
| 0.9 |
0.9 |
GO:0050717 |
positive regulation of interleukin-1 alpha secretion(GO:0050717) |
| 0.9 |
2.6 |
GO:0043006 |
activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
| 0.9 |
7.9 |
GO:2000620 |
positive regulation of histone H4-K16 acetylation(GO:2000620) |
| 0.9 |
3.5 |
GO:0033693 |
neurofilament bundle assembly(GO:0033693) |
| 0.9 |
2.6 |
GO:0034148 |
regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) |
| 0.9 |
2.6 |
GO:0046521 |
sphingoid catabolic process(GO:0046521) |
| 0.9 |
7.7 |
GO:0061302 |
smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.8 |
6.6 |
GO:0061709 |
reticulophagy(GO:0061709) |
| 0.8 |
2.4 |
GO:0060166 |
olfactory pit development(GO:0060166) |
| 0.8 |
2.4 |
GO:0038195 |
urokinase plasminogen activator signaling pathway(GO:0038195) |
| 0.8 |
3.2 |
GO:0042335 |
cuticle development(GO:0042335) |
| 0.8 |
2.4 |
GO:1903572 |
regulation of protein kinase D signaling(GO:1903570) positive regulation of protein kinase D signaling(GO:1903572) |
| 0.8 |
1.6 |
GO:0051040 |
regulation of calcium-independent cell-cell adhesion(GO:0051040) |
| 0.8 |
4.8 |
GO:0030311 |
poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 0.8 |
2.4 |
GO:1903028 |
positive regulation of opsonization(GO:1903028) |
| 0.8 |
3.1 |
GO:0010980 |
regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
| 0.8 |
3.9 |
GO:0044752 |
response to human chorionic gonadotropin(GO:0044752) |
| 0.8 |
2.3 |
GO:0048560 |
establishment of anatomical structure orientation(GO:0048560) |
| 0.8 |
1.5 |
GO:0045168 |
cell-cell signaling involved in cell fate commitment(GO:0045168) |
| 0.8 |
2.3 |
GO:0070902 |
mitochondrial tRNA pseudouridine synthesis(GO:0070902) |
| 0.8 |
0.8 |
GO:1905007 |
positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905007) |
| 0.8 |
0.8 |
GO:0086029 |
Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
| 0.8 |
2.3 |
GO:0009720 |
detection of hormone stimulus(GO:0009720) |
| 0.7 |
2.2 |
GO:0061163 |
endoplasmic reticulum polarization(GO:0061163) actin filament bundle retrograde transport(GO:0061573) actin filament bundle distribution(GO:0070650) |
| 0.7 |
5.9 |
GO:0086073 |
bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
| 0.7 |
2.9 |
GO:0090095 |
regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 0.7 |
2.9 |
GO:1904154 |
positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.7 |
1.5 |
GO:0060557 |
positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
| 0.7 |
2.2 |
GO:0048320 |
axial mesoderm formation(GO:0048320) |
| 0.7 |
3.5 |
GO:1904222 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.7 |
1.4 |
GO:0002543 |
activation of blood coagulation via clotting cascade(GO:0002543) |
| 0.7 |
2.8 |
GO:0018894 |
dibenzo-p-dioxin metabolic process(GO:0018894) |
| 0.7 |
2.8 |
GO:0045226 |
extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
| 0.7 |
4.1 |
GO:0031133 |
regulation of axon diameter(GO:0031133) |
| 0.7 |
2.7 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.7 |
2.0 |
GO:1903984 |
positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 0.7 |
4.7 |
GO:0061589 |
calcium activated phosphatidylserine scrambling(GO:0061589) |
| 0.7 |
2.7 |
GO:0031117 |
positive regulation of microtubule depolymerization(GO:0031117) |
| 0.7 |
5.3 |
GO:0015705 |
iodide transport(GO:0015705) |
| 0.7 |
0.7 |
GO:0016264 |
gap junction assembly(GO:0016264) |
| 0.6 |
6.5 |
GO:0051547 |
regulation of keratinocyte migration(GO:0051547) |
| 0.6 |
3.2 |
GO:0032929 |
negative regulation of superoxide anion generation(GO:0032929) |
| 0.6 |
0.6 |
GO:1904954 |
canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904954) |
| 0.6 |
1.3 |
GO:0001579 |
medium-chain fatty acid transport(GO:0001579) |
| 0.6 |
1.3 |
GO:0031938 |
regulation of chromatin silencing at telomere(GO:0031938) |
| 0.6 |
1.3 |
GO:0051673 |
membrane disruption in other organism(GO:0051673) |
| 0.6 |
1.9 |
GO:0046586 |
regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 0.6 |
1.9 |
GO:0006663 |
platelet activating factor biosynthetic process(GO:0006663) |
| 0.6 |
1.2 |
GO:0010652 |
regulation of cell communication by chemical coupling(GO:0010645) positive regulation of cell communication by chemical coupling(GO:0010652) |
| 0.6 |
6.7 |
GO:0038026 |
reelin-mediated signaling pathway(GO:0038026) |
| 0.6 |
3.1 |
GO:0071109 |
superior temporal gyrus development(GO:0071109) |
| 0.6 |
3.0 |
GO:1903238 |
positive regulation of leukocyte tethering or rolling(GO:1903238) |
| 0.6 |
3.0 |
GO:0018352 |
protein-pyridoxal-5-phosphate linkage(GO:0018352) |
| 0.6 |
3.6 |
GO:0051958 |
methotrexate transport(GO:0051958) |
| 0.6 |
4.2 |
GO:0042271 |
susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 0.6 |
1.8 |
GO:0033037 |
polysaccharide localization(GO:0033037) |
| 0.6 |
1.2 |
GO:0048867 |
stem cell fate determination(GO:0048867) |
| 0.6 |
2.3 |
GO:0060708 |
spongiotrophoblast differentiation(GO:0060708) |
| 0.6 |
1.2 |
GO:1904170 |
regulation of bleb assembly(GO:1904170) positive regulation of bleb assembly(GO:1904172) |
| 0.6 |
3.4 |
GO:0051182 |
coenzyme transport(GO:0051182) |
| 0.6 |
5.1 |
GO:0070673 |
response to interleukin-18(GO:0070673) |
| 0.6 |
2.8 |
GO:0090362 |
positive regulation of platelet-derived growth factor production(GO:0090362) |
| 0.6 |
1.7 |
GO:0005988 |
lactose metabolic process(GO:0005988) lactose biosynthetic process(GO:0005989) |
| 0.6 |
1.1 |
GO:0003104 |
positive regulation of glomerular filtration(GO:0003104) |
| 0.6 |
2.8 |
GO:1904693 |
midbrain morphogenesis(GO:1904693) |
| 0.6 |
1.7 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.6 |
1.7 |
GO:0043973 |
histone H3-K4 acetylation(GO:0043973) |
| 0.6 |
2.2 |
GO:0060061 |
Spemann organizer formation(GO:0060061) |
| 0.6 |
1.7 |
GO:0042938 |
dipeptide transport(GO:0042938) |
| 0.6 |
2.2 |
GO:0000915 |
assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 0.6 |
6.1 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
| 0.5 |
1.6 |
GO:0018057 |
peptidyl-lysine oxidation(GO:0018057) |
| 0.5 |
1.6 |
GO:0015917 |
aminophospholipid transport(GO:0015917) |
| 0.5 |
0.5 |
GO:0042256 |
mature ribosome assembly(GO:0042256) |
| 0.5 |
4.8 |
GO:0006686 |
sphingomyelin biosynthetic process(GO:0006686) |
| 0.5 |
1.6 |
GO:1904844 |
response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
| 0.5 |
1.6 |
GO:1902769 |
regulation of choline O-acetyltransferase activity(GO:1902769) positive regulation of choline O-acetyltransferase activity(GO:1902771) negative regulation of tau-protein kinase activity(GO:1902948) positive regulation of early endosome to recycling endosome transport(GO:1902955) negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902960) negative regulation of neurofibrillary tangle assembly(GO:1902997) negative regulation of aspartic-type peptidase activity(GO:1905246) |
| 0.5 |
2.1 |
GO:0010585 |
glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
| 0.5 |
1.6 |
GO:0061502 |
early endosome to recycling endosome transport(GO:0061502) |
| 0.5 |
3.1 |
GO:0006196 |
AMP catabolic process(GO:0006196) |
| 0.5 |
2.1 |
GO:0002238 |
response to molecule of fungal origin(GO:0002238) cellular response to molecule of fungal origin(GO:0071226) |
| 0.5 |
1.6 |
GO:0006478 |
peptidyl-tyrosine sulfation(GO:0006478) |
| 0.5 |
3.1 |
GO:1901731 |
positive regulation of platelet aggregation(GO:1901731) |
| 0.5 |
1.0 |
GO:1900127 |
positive regulation of hyaluronan biosynthetic process(GO:1900127) |
| 0.5 |
0.5 |
GO:0051295 |
establishment of meiotic spindle localization(GO:0051295) |
| 0.5 |
16.6 |
GO:0035590 |
purinergic nucleotide receptor signaling pathway(GO:0035590) |
| 0.5 |
3.6 |
GO:0097461 |
ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
| 0.5 |
2.1 |
GO:0032808 |
lacrimal gland development(GO:0032808) |
| 0.5 |
1.6 |
GO:0002538 |
arachidonic acid metabolite production involved in inflammatory response(GO:0002538) leukotriene production involved in inflammatory response(GO:0002540) |
| 0.5 |
7.2 |
GO:0021796 |
cerebral cortex regionalization(GO:0021796) |
| 0.5 |
2.6 |
GO:2000563 |
positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
| 0.5 |
3.1 |
GO:0030860 |
regulation of polarized epithelial cell differentiation(GO:0030860) |
| 0.5 |
0.5 |
GO:2000847 |
negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
| 0.5 |
4.1 |
GO:0002943 |
tRNA dihydrouridine synthesis(GO:0002943) |
| 0.5 |
1.5 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.5 |
2.0 |
GO:0030200 |
heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.5 |
4.5 |
GO:0051122 |
hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
| 0.5 |
1.5 |
GO:0007538 |
primary sex determination(GO:0007538) |
| 0.5 |
10.9 |
GO:0090026 |
positive regulation of monocyte chemotaxis(GO:0090026) |
| 0.5 |
0.5 |
GO:0032765 |
positive regulation of mast cell cytokine production(GO:0032765) |
| 0.5 |
2.5 |
GO:0009181 |
purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 0.5 |
1.5 |
GO:1904502 |
regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
| 0.5 |
8.8 |
GO:0045741 |
positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 0.5 |
2.9 |
GO:0032468 |
Golgi calcium ion homeostasis(GO:0032468) |
| 0.5 |
4.3 |
GO:0060744 |
thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
| 0.5 |
1.4 |
GO:1990569 |
UDP-N-acetylglucosamine transport(GO:0015788) UDP-N-acetylglucosamine transmembrane transport(GO:1990569) |
| 0.5 |
0.5 |
GO:0000466 |
maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
| 0.5 |
1.0 |
GO:0002541 |
activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
| 0.5 |
2.4 |
GO:0086048 |
membrane depolarization during bundle of His cell action potential(GO:0086048) |
| 0.5 |
1.4 |
GO:0046108 |
uridine metabolic process(GO:0046108) |
| 0.5 |
3.8 |
GO:0044806 |
G-quadruplex DNA unwinding(GO:0044806) |
| 0.5 |
3.2 |
GO:0010482 |
epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
| 0.5 |
7.3 |
GO:0035269 |
protein O-linked mannosylation(GO:0035269) |
| 0.5 |
2.3 |
GO:0043988 |
histone H3-S28 phosphorylation(GO:0043988) |
| 0.5 |
2.3 |
GO:0003431 |
growth plate cartilage chondrocyte development(GO:0003431) |
| 0.5 |
1.4 |
GO:0044771 |
meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) negative regulation of meiotic cell cycle phase transition(GO:1901994) |
| 0.5 |
1.4 |
GO:0060309 |
elastin catabolic process(GO:0060309) |
| 0.5 |
3.2 |
GO:2000048 |
negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.4 |
0.4 |
GO:0002085 |
inhibition of neuroepithelial cell differentiation(GO:0002085) |
| 0.4 |
0.4 |
GO:0045084 |
positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
| 0.4 |
1.8 |
GO:0044210 |
'de novo' CTP biosynthetic process(GO:0044210) |
| 0.4 |
1.8 |
GO:0070295 |
renal water absorption(GO:0070295) |
| 0.4 |
1.3 |
GO:0014012 |
peripheral nervous system axon regeneration(GO:0014012) |
| 0.4 |
4.5 |
GO:0070574 |
cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
| 0.4 |
0.4 |
GO:1902174 |
positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 0.4 |
1.3 |
GO:2000276 |
negative regulation of oxidative phosphorylation uncoupler activity(GO:2000276) |
| 0.4 |
0.9 |
GO:0009405 |
pathogenesis(GO:0009405) |
| 0.4 |
1.8 |
GO:0000961 |
negative regulation of mitochondrial RNA catabolic process(GO:0000961) |
| 0.4 |
0.4 |
GO:0006382 |
adenosine to inosine editing(GO:0006382) |
| 0.4 |
8.0 |
GO:0016540 |
protein autoprocessing(GO:0016540) |
| 0.4 |
0.4 |
GO:0045110 |
intermediate filament bundle assembly(GO:0045110) |
| 0.4 |
1.8 |
GO:1903371 |
regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
| 0.4 |
1.3 |
GO:0036466 |
synaptic vesicle recycling via endosome(GO:0036466) |
| 0.4 |
0.4 |
GO:0030321 |
transepithelial chloride transport(GO:0030321) |
| 0.4 |
2.2 |
GO:0050689 |
negative regulation of defense response to virus by host(GO:0050689) |
| 0.4 |
1.7 |
GO:0043335 |
protein unfolding(GO:0043335) |
| 0.4 |
1.3 |
GO:2001287 |
negative regulation of caveolin-mediated endocytosis(GO:2001287) |
| 0.4 |
1.3 |
GO:0034471 |
endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000472) rRNA 5'-end processing(GO:0000967) ncRNA 5'-end processing(GO:0034471) |
| 0.4 |
0.4 |
GO:0061289 |
cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
| 0.4 |
0.4 |
GO:2000562 |
CD4-positive, alpha-beta T cell proliferation(GO:0035739) regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
| 0.4 |
0.9 |
GO:1903233 |
regulation of calcium ion-dependent exocytosis of neurotransmitter(GO:1903233) |
| 0.4 |
1.7 |
GO:1904694 |
negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.4 |
5.5 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
| 0.4 |
3.0 |
GO:1900264 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.4 |
3.4 |
GO:0071681 |
response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
| 0.4 |
1.7 |
GO:0070973 |
protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.4 |
0.8 |
GO:1900425 |
negative regulation of defense response to bacterium(GO:1900425) |
| 0.4 |
1.7 |
GO:1990481 |
mRNA pseudouridine synthesis(GO:1990481) |
| 0.4 |
2.5 |
GO:0010025 |
wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.4 |
3.3 |
GO:0002329 |
pre-B cell differentiation(GO:0002329) |
| 0.4 |
2.1 |
GO:0060282 |
positive regulation of oocyte development(GO:0060282) |
| 0.4 |
0.4 |
GO:0060197 |
cloacal septation(GO:0060197) |
| 0.4 |
2.5 |
GO:0038172 |
interleukin-33-mediated signaling pathway(GO:0038172) |
| 0.4 |
3.3 |
GO:0032218 |
riboflavin transport(GO:0032218) |
| 0.4 |
1.2 |
GO:0032185 |
septin cytoskeleton organization(GO:0032185) |
| 0.4 |
0.4 |
GO:0030167 |
proteoglycan catabolic process(GO:0030167) |
| 0.4 |
0.8 |
GO:0048319 |
axial mesoderm morphogenesis(GO:0048319) |
| 0.4 |
2.9 |
GO:0002934 |
desmosome organization(GO:0002934) |
| 0.4 |
1.6 |
GO:0010760 |
negative regulation of macrophage chemotaxis(GO:0010760) |
| 0.4 |
0.8 |
GO:0036269 |
swimming behavior(GO:0036269) |
| 0.4 |
1.6 |
GO:0018199 |
peptidyl-glutamine modification(GO:0018199) |
| 0.4 |
1.6 |
GO:1905224 |
clathrin-coated pit assembly(GO:1905224) |
| 0.4 |
1.2 |
GO:0045013 |
carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 0.4 |
4.8 |
GO:1900625 |
regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
| 0.4 |
1.6 |
GO:0000738 |
DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.4 |
1.6 |
GO:0001897 |
cytolysis by symbiont of host cells(GO:0001897) |
| 0.4 |
1.6 |
GO:1990535 |
neuron projection maintenance(GO:1990535) |
| 0.4 |
1.2 |
GO:1902462 |
regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.4 |
1.6 |
GO:0036483 |
neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0036483) regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903381) negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903382) |
| 0.4 |
3.6 |
GO:0048875 |
chemical homeostasis within a tissue(GO:0048875) |
| 0.4 |
0.8 |
GO:0089709 |
histidine transport(GO:0015817) L-histidine transmembrane transport(GO:0089709) L-histidine transport(GO:1902024) |
| 0.4 |
2.0 |
GO:0051546 |
keratinocyte migration(GO:0051546) |
| 0.4 |
3.1 |
GO:0042985 |
negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.4 |
2.0 |
GO:0036149 |
phosphatidylinositol acyl-chain remodeling(GO:0036149) |
| 0.4 |
4.7 |
GO:2001288 |
positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 0.4 |
0.4 |
GO:0071035 |
polyadenylation-dependent RNA catabolic process(GO:0043633) polyadenylation-dependent ncRNA catabolic process(GO:0043634) nuclear ncRNA surveillance(GO:0071029) nuclear polyadenylation-dependent rRNA catabolic process(GO:0071035) nuclear polyadenylation-dependent ncRNA catabolic process(GO:0071046) |
| 0.4 |
1.2 |
GO:1901899 |
positive regulation of relaxation of cardiac muscle(GO:1901899) |
| 0.4 |
1.2 |
GO:0060739 |
mesenchymal-epithelial cell signaling involved in prostate gland development(GO:0060739) |
| 0.4 |
1.5 |
GO:0034164 |
negative regulation of toll-like receptor 9 signaling pathway(GO:0034164) |
| 0.4 |
3.1 |
GO:0034350 |
regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
| 0.4 |
0.8 |
GO:0042369 |
vitamin D catabolic process(GO:0042369) |
| 0.4 |
3.5 |
GO:0035087 |
siRNA loading onto RISC involved in RNA interference(GO:0035087) |
| 0.4 |
4.2 |
GO:0007028 |
cytoplasm organization(GO:0007028) |
| 0.4 |
1.5 |
GO:0034344 |
type III interferon production(GO:0034343) regulation of type III interferon production(GO:0034344) |
| 0.4 |
1.1 |
GO:2000503 |
positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 0.4 |
1.9 |
GO:1990426 |
homologous recombination-dependent replication fork processing(GO:1990426) |
| 0.4 |
0.7 |
GO:0090521 |
glomerular visceral epithelial cell migration(GO:0090521) |
| 0.4 |
0.4 |
GO:1904868 |
telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
| 0.4 |
4.1 |
GO:0009950 |
dorsal/ventral axis specification(GO:0009950) |
| 0.4 |
1.5 |
GO:0002913 |
positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 0.4 |
2.2 |
GO:0038016 |
insulin receptor internalization(GO:0038016) |
| 0.4 |
1.5 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
| 0.4 |
1.5 |
GO:0009257 |
10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
| 0.4 |
0.7 |
GO:0001560 |
regulation of cell growth by extracellular stimulus(GO:0001560) |
| 0.4 |
1.5 |
GO:0038018 |
Wnt receptor catabolic process(GO:0038018) |
| 0.4 |
1.1 |
GO:0043987 |
histone H3-S10 phosphorylation(GO:0043987) |
| 0.4 |
11.9 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.4 |
2.2 |
GO:0032237 |
activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.4 |
1.1 |
GO:0002415 |
immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
| 0.4 |
2.8 |
GO:0015712 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.4 |
2.1 |
GO:1903588 |
negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
| 0.4 |
1.1 |
GO:0061027 |
umbilical cord morphogenesis(GO:0036304) umbilical cord development(GO:0061027) |
| 0.4 |
4.6 |
GO:0032119 |
sequestering of zinc ion(GO:0032119) |
| 0.4 |
1.1 |
GO:0060528 |
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.4 |
1.4 |
GO:2000681 |
negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
| 0.4 |
0.7 |
GO:1903691 |
positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
| 0.3 |
4.5 |
GO:0006971 |
hypotonic response(GO:0006971) |
| 0.3 |
0.3 |
GO:1902823 |
negative regulation of late endosome to lysosome transport(GO:1902823) |
| 0.3 |
3.5 |
GO:0002480 |
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 0.3 |
0.7 |
GO:0030185 |
nitric oxide transport(GO:0030185) |
| 0.3 |
1.0 |
GO:0036451 |
cap mRNA methylation(GO:0036451) |
| 0.3 |
2.8 |
GO:0070863 |
positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.3 |
1.4 |
GO:0035701 |
hematopoietic stem cell migration(GO:0035701) |
| 0.3 |
1.7 |
GO:0090481 |
pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
| 0.3 |
0.3 |
GO:0002725 |
negative regulation of T cell cytokine production(GO:0002725) |
| 0.3 |
5.8 |
GO:0046415 |
urate metabolic process(GO:0046415) |
| 0.3 |
3.4 |
GO:0051918 |
negative regulation of fibrinolysis(GO:0051918) |
| 0.3 |
8.2 |
GO:0051639 |
actin filament network formation(GO:0051639) |
| 0.3 |
1.0 |
GO:0035507 |
regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.3 |
3.7 |
GO:0006670 |
sphingosine metabolic process(GO:0006670) |
| 0.3 |
0.7 |
GO:1902567 |
negative regulation of eosinophil activation(GO:1902567) |
| 0.3 |
1.7 |
GO:0035585 |
calcium-mediated signaling using extracellular calcium source(GO:0035585) |
| 0.3 |
4.4 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.3 |
0.7 |
GO:0007290 |
spermatid nucleus elongation(GO:0007290) |
| 0.3 |
0.7 |
GO:0033629 |
negative regulation of cell adhesion mediated by integrin(GO:0033629) |
| 0.3 |
1.0 |
GO:0071163 |
DNA replication preinitiation complex assembly(GO:0071163) |
| 0.3 |
2.7 |
GO:1903830 |
magnesium ion transmembrane transport(GO:1903830) |
| 0.3 |
1.0 |
GO:0090222 |
centrosome-templated microtubule nucleation(GO:0090222) |
| 0.3 |
0.7 |
GO:0030886 |
negative regulation of myeloid dendritic cell activation(GO:0030886) |
| 0.3 |
1.7 |
GO:1904751 |
positive regulation of protein localization to nucleolus(GO:1904751) |
| 0.3 |
3.3 |
GO:0038145 |
macrophage colony-stimulating factor signaling pathway(GO:0038145) |
| 0.3 |
4.0 |
GO:0098734 |
macromolecule depalmitoylation(GO:0098734) |
| 0.3 |
4.0 |
GO:0042574 |
retinal metabolic process(GO:0042574) |
| 0.3 |
1.0 |
GO:0035747 |
natural killer cell chemotaxis(GO:0035747) |
| 0.3 |
1.3 |
GO:2000173 |
negative regulation of dendrite extension(GO:1903860) regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
| 0.3 |
1.0 |
GO:2000017 |
positive regulation of determination of dorsal identity(GO:2000017) |
| 0.3 |
1.3 |
GO:0003199 |
endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
| 0.3 |
2.6 |
GO:1902219 |
negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
| 0.3 |
1.0 |
GO:0051533 |
positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.3 |
11.0 |
GO:0007141 |
male meiosis I(GO:0007141) |
| 0.3 |
0.6 |
GO:1903281 |
positive regulation of calcium:sodium antiporter activity(GO:1903281) |
| 0.3 |
1.6 |
GO:0002357 |
defense response to tumor cell(GO:0002357) |
| 0.3 |
0.3 |
GO:0071404 |
cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
| 0.3 |
1.3 |
GO:0051944 |
positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
| 0.3 |
2.9 |
GO:0090232 |
positive regulation of spindle checkpoint(GO:0090232) |
| 0.3 |
1.0 |
GO:0060003 |
copper ion export(GO:0060003) |
| 0.3 |
0.6 |
GO:1904440 |
positive regulation of iron ion transport(GO:0034758) positive regulation of iron ion transmembrane transport(GO:0034761) regulation of iron ion import(GO:1900390) regulation of ferrous iron import into cell(GO:1903989) positive regulation of ferrous iron import into cell(GO:1903991) regulation of ferrous iron binding(GO:1904432) positive regulation of ferrous iron binding(GO:1904434) regulation of transferrin receptor binding(GO:1904435) positive regulation of transferrin receptor binding(GO:1904437) regulation of ferrous iron import across plasma membrane(GO:1904438) positive regulation of ferrous iron import across plasma membrane(GO:1904440) |
| 0.3 |
5.0 |
GO:0038203 |
TORC2 signaling(GO:0038203) |
| 0.3 |
1.3 |
GO:1990523 |
bone regeneration(GO:1990523) |
| 0.3 |
0.6 |
GO:0043397 |
corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) |
| 0.3 |
0.9 |
GO:0006391 |
transcription initiation from mitochondrial promoter(GO:0006391) |
| 0.3 |
1.6 |
GO:0060763 |
mammary duct terminal end bud growth(GO:0060763) |
| 0.3 |
1.9 |
GO:0048165 |
ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
| 0.3 |
6.9 |
GO:0051292 |
nuclear pore complex assembly(GO:0051292) |
| 0.3 |
2.2 |
GO:0036089 |
cleavage furrow formation(GO:0036089) |
| 0.3 |
1.2 |
GO:1903288 |
positive regulation of potassium ion import(GO:1903288) |
| 0.3 |
4.0 |
GO:1901838 |
positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
| 0.3 |
2.2 |
GO:0043615 |
astrocyte cell migration(GO:0043615) |
| 0.3 |
2.2 |
GO:0000821 |
regulation of arginine metabolic process(GO:0000821) |
| 0.3 |
0.9 |
GO:1900864 |
mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
| 0.3 |
0.3 |
GO:0010958 |
regulation of amino acid import(GO:0010958) |
| 0.3 |
0.3 |
GO:0097695 |
establishment of RNA localization to telomere(GO:0097694) establishment of macromolecular complex localization to telomere(GO:0097695) |
| 0.3 |
3.1 |
GO:0006516 |
glycoprotein catabolic process(GO:0006516) |
| 0.3 |
3.7 |
GO:0060700 |
regulation of ribonuclease activity(GO:0060700) |
| 0.3 |
0.6 |
GO:0035641 |
locomotory exploration behavior(GO:0035641) |
| 0.3 |
0.3 |
GO:0002625 |
regulation of T cell antigen processing and presentation(GO:0002625) |
| 0.3 |
4.3 |
GO:1901642 |
nucleoside transmembrane transport(GO:1901642) |
| 0.3 |
0.9 |
GO:0060373 |
regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
| 0.3 |
1.2 |
GO:0086043 |
bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
| 0.3 |
1.2 |
GO:1902474 |
positive regulation of protein localization to synapse(GO:1902474) |
| 0.3 |
0.3 |
GO:2000182 |
regulation of progesterone biosynthetic process(GO:2000182) |
| 0.3 |
0.9 |
GO:0002679 |
respiratory burst involved in defense response(GO:0002679) |
| 0.3 |
0.3 |
GO:0032641 |
lymphotoxin A production(GO:0032641) lymphotoxin A biosynthetic process(GO:0042109) |
| 0.3 |
1.8 |
GO:0036493 |
positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
| 0.3 |
0.6 |
GO:0001300 |
chronological cell aging(GO:0001300) |
| 0.3 |
0.6 |
GO:0071557 |
histone H3-K27 demethylation(GO:0071557) |
| 0.3 |
3.6 |
GO:0090361 |
platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 0.3 |
1.2 |
GO:0033159 |
negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 0.3 |
1.2 |
GO:0034224 |
cellular response to zinc ion starvation(GO:0034224) |
| 0.3 |
0.6 |
GO:2000863 |
positive regulation of estrogen secretion(GO:2000863) positive regulation of estradiol secretion(GO:2000866) |
| 0.3 |
5.0 |
GO:0045078 |
positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.3 |
1.2 |
GO:0048073 |
regulation of eye pigmentation(GO:0048073) |
| 0.3 |
0.9 |
GO:0035574 |
histone H4-K20 demethylation(GO:0035574) |
| 0.3 |
3.8 |
GO:0035095 |
behavioral response to nicotine(GO:0035095) |
| 0.3 |
0.9 |
GO:1990922 |
regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
| 0.3 |
6.7 |
GO:0051085 |
chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.3 |
2.0 |
GO:1900045 |
negative regulation of histone ubiquitination(GO:0033183) negative regulation of protein K63-linked ubiquitination(GO:1900045) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) negative regulation of protein polyubiquitination(GO:1902915) |
| 0.3 |
1.4 |
GO:1904207 |
regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
| 0.3 |
5.5 |
GO:0036148 |
phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
| 0.3 |
3.2 |
GO:1902572 |
negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
| 0.3 |
0.3 |
GO:0033076 |
isoquinoline alkaloid metabolic process(GO:0033076) |
| 0.3 |
1.1 |
GO:0035712 |
T-helper 2 cell activation(GO:0035712) regulation of T-helper 2 cell activation(GO:2000569) positive regulation of T-helper 2 cell activation(GO:2000570) |
| 0.3 |
0.3 |
GO:1903949 |
positive regulation of atrial cardiac muscle cell action potential(GO:1903949) |
| 0.3 |
0.9 |
GO:0050893 |
sensory processing(GO:0050893) |
| 0.3 |
1.1 |
GO:2001247 |
positive regulation of phosphatidylcholine biosynthetic process(GO:2001247) |
| 0.3 |
0.9 |
GO:0032877 |
positive regulation of DNA endoreduplication(GO:0032877) |
| 0.3 |
0.6 |
GO:1904749 |
regulation of protein localization to nucleolus(GO:1904749) |
| 0.3 |
1.4 |
GO:0050859 |
negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 0.3 |
31.8 |
GO:0070268 |
cornification(GO:0070268) |
| 0.3 |
1.7 |
GO:0010032 |
meiotic chromosome condensation(GO:0010032) |
| 0.3 |
0.3 |
GO:0002361 |
CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
| 0.3 |
6.5 |
GO:0016254 |
preassembly of GPI anchor in ER membrane(GO:0016254) |
| 0.3 |
0.9 |
GO:0021722 |
superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
| 0.3 |
1.7 |
GO:0032439 |
endosome localization(GO:0032439) |
| 0.3 |
1.7 |
GO:0001923 |
B-1 B cell differentiation(GO:0001923) |
| 0.3 |
0.3 |
GO:0015677 |
copper ion import(GO:0015677) |
| 0.3 |
0.8 |
GO:2000193 |
positive regulation of fatty acid transport(GO:2000193) |
| 0.3 |
1.1 |
GO:1900827 |
maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 0.3 |
0.8 |
GO:0043012 |
regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
| 0.3 |
0.8 |
GO:0090031 |
positive regulation of steroid hormone biosynthetic process(GO:0090031) |
| 0.3 |
1.7 |
GO:0007079 |
mitotic chromosome movement towards spindle pole(GO:0007079) |
| 0.3 |
0.3 |
GO:1903541 |
regulation of exosomal secretion(GO:1903541) |
| 0.3 |
0.6 |
GO:0048496 |
maintenance of organ identity(GO:0048496) |
| 0.3 |
0.8 |
GO:0072272 |
proximal/distal pattern formation involved in metanephric nephron development(GO:0072272) |
| 0.3 |
0.8 |
GO:0098971 |
anterograde dendritic transport of neurotransmitter receptor complex(GO:0098971) |
| 0.3 |
0.8 |
GO:0061537 |
glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 0.3 |
0.8 |
GO:0045715 |
negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
| 0.3 |
0.6 |
GO:0098759 |
response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
| 0.3 |
0.6 |
GO:2000977 |
regulation of forebrain neuron differentiation(GO:2000977) |
| 0.3 |
1.1 |
GO:1904058 |
positive regulation of sensory perception of pain(GO:1904058) |
| 0.3 |
0.8 |
GO:0006421 |
asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.3 |
0.3 |
GO:0009794 |
regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.3 |
3.6 |
GO:0019317 |
fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
| 0.3 |
6.3 |
GO:0014733 |
regulation of skeletal muscle adaptation(GO:0014733) |
| 0.3 |
1.9 |
GO:1900121 |
negative regulation of receptor binding(GO:1900121) |
| 0.3 |
2.2 |
GO:0035469 |
determination of pancreatic left/right asymmetry(GO:0035469) |
| 0.3 |
1.4 |
GO:0002138 |
retinoic acid biosynthetic process(GO:0002138) |
| 0.3 |
3.0 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.3 |
0.5 |
GO:2000504 |
positive regulation of blood vessel remodeling(GO:2000504) |
| 0.3 |
1.4 |
GO:0007198 |
adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
| 0.3 |
0.3 |
GO:1904862 |
inhibitory synapse assembly(GO:1904862) |
| 0.3 |
0.3 |
GO:2000777 |
positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
| 0.3 |
1.4 |
GO:0001575 |
globoside metabolic process(GO:0001575) |
| 0.3 |
1.1 |
GO:2000587 |
negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
| 0.3 |
1.6 |
GO:0033489 |
cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
| 0.3 |
0.3 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.3 |
1.1 |
GO:0046946 |
hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.3 |
0.5 |
GO:0021553 |
olfactory nerve development(GO:0021553) |
| 0.3 |
4.0 |
GO:0032926 |
negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.3 |
1.1 |
GO:0045065 |
cytotoxic T cell differentiation(GO:0045065) |
| 0.3 |
1.6 |
GO:0060214 |
endocardium formation(GO:0060214) |
| 0.3 |
2.9 |
GO:0000463 |
maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.3 |
0.3 |
GO:0060268 |
negative regulation of respiratory burst(GO:0060268) |
| 0.3 |
0.8 |
GO:0018002 |
N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.3 |
1.1 |
GO:0071725 |
toll-like receptor TLR1:TLR2 signaling pathway(GO:0038123) response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
| 0.3 |
1.1 |
GO:0002074 |
extraocular skeletal muscle development(GO:0002074) |
| 0.3 |
0.3 |
GO:0045041 |
protein import into mitochondrial intermembrane space(GO:0045041) |
| 0.3 |
0.5 |
GO:0033686 |
positive regulation of luteinizing hormone secretion(GO:0033686) |
| 0.3 |
0.3 |
GO:1904220 |
regulation of serine C-palmitoyltransferase activity(GO:1904220) |
| 0.3 |
5.6 |
GO:0016024 |
CDP-diacylglycerol biosynthetic process(GO:0016024) |
| 0.3 |
0.8 |
GO:0001951 |
intestinal D-glucose absorption(GO:0001951) |
| 0.3 |
1.1 |
GO:0003409 |
optic cup structural organization(GO:0003409) |
| 0.3 |
1.3 |
GO:1901091 |
regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
| 0.3 |
0.5 |
GO:0000960 |
mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
| 0.3 |
1.3 |
GO:1903385 |
regulation of homophilic cell adhesion(GO:1903385) |
| 0.3 |
0.5 |
GO:2000586 |
regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) |
| 0.3 |
0.5 |
GO:1900222 |
negative regulation of beta-amyloid clearance(GO:1900222) |
| 0.3 |
3.7 |
GO:0006600 |
creatine metabolic process(GO:0006600) |
| 0.3 |
0.5 |
GO:0071895 |
odontoblast differentiation(GO:0071895) |
| 0.3 |
0.8 |
GO:0042997 |
negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 0.3 |
1.0 |
GO:1901842 |
negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 0.3 |
2.1 |
GO:0031339 |
negative regulation of vesicle fusion(GO:0031339) |
| 0.3 |
2.3 |
GO:1902412 |
regulation of mitotic cytokinesis(GO:1902412) |
| 0.3 |
1.0 |
GO:0032747 |
positive regulation of interleukin-23 production(GO:0032747) |
| 0.3 |
0.3 |
GO:0051695 |
actin filament uncapping(GO:0051695) |
| 0.3 |
1.0 |
GO:2000393 |
negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 0.3 |
15.8 |
GO:0015701 |
bicarbonate transport(GO:0015701) |
| 0.3 |
1.6 |
GO:2000234 |
positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
| 0.3 |
0.5 |
GO:0034165 |
positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
| 0.3 |
0.3 |
GO:0015798 |
myo-inositol transport(GO:0015798) |
| 0.3 |
0.3 |
GO:0060718 |
chorionic trophoblast cell differentiation(GO:0060718) |
| 0.3 |
1.0 |
GO:1902775 |
mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.3 |
1.3 |
GO:0051708 |
intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.3 |
1.5 |
GO:2000609 |
regulation of thyroid hormone generation(GO:2000609) |
| 0.3 |
0.5 |
GO:0007412 |
axon target recognition(GO:0007412) |
| 0.3 |
0.3 |
GO:1903721 |
regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
| 0.3 |
0.8 |
GO:0044205 |
'de novo' UMP biosynthetic process(GO:0044205) |
| 0.3 |
0.8 |
GO:0009635 |
response to herbicide(GO:0009635) |
| 0.3 |
2.3 |
GO:0032525 |
somite rostral/caudal axis specification(GO:0032525) |
| 0.3 |
0.8 |
GO:0019046 |
release from viral latency(GO:0019046) |
| 0.3 |
10.9 |
GO:1901998 |
toxin transport(GO:1901998) |
| 0.3 |
1.8 |
GO:0030421 |
defecation(GO:0030421) |
| 0.3 |
0.8 |
GO:1903912 |
negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
| 0.3 |
1.0 |
GO:0045631 |
regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.3 |
0.3 |
GO:0048633 |
positive regulation of skeletal muscle tissue growth(GO:0048633) |
| 0.3 |
1.5 |
GO:0034472 |
snRNA 3'-end processing(GO:0034472) |
| 0.2 |
0.2 |
GO:0060723 |
spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
| 0.2 |
2.0 |
GO:0016255 |
attachment of GPI anchor to protein(GO:0016255) |
| 0.2 |
0.7 |
GO:0002528 |
regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
| 0.2 |
1.5 |
GO:0021800 |
cerebral cortex tangential migration(GO:0021800) |
| 0.2 |
0.7 |
GO:0010956 |
negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
| 0.2 |
1.0 |
GO:0030035 |
microspike assembly(GO:0030035) |
| 0.2 |
0.7 |
GO:0071286 |
cellular response to magnesium ion(GO:0071286) |
| 0.2 |
1.5 |
GO:0035063 |
nuclear speck organization(GO:0035063) |
| 0.2 |
0.2 |
GO:0060056 |
mammary gland involution(GO:0060056) |
| 0.2 |
2.0 |
GO:0015014 |
heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.2 |
0.7 |
GO:0001732 |
formation of cytoplasmic translation initiation complex(GO:0001732) |
| 0.2 |
1.7 |
GO:0090666 |
scaRNA localization to Cajal body(GO:0090666) |
| 0.2 |
1.5 |
GO:0032252 |
secretory granule localization(GO:0032252) |
| 0.2 |
1.5 |
GO:0000727 |
double-strand break repair via break-induced replication(GO:0000727) |
| 0.2 |
1.2 |
GO:0071787 |
endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.2 |
0.7 |
GO:0060287 |
epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
| 0.2 |
0.5 |
GO:0090235 |
regulation of metaphase plate congression(GO:0090235) |
| 0.2 |
1.2 |
GO:0015747 |
urate transport(GO:0015747) |
| 0.2 |
2.4 |
GO:0002475 |
antigen processing and presentation via MHC class Ib(GO:0002475) |
| 0.2 |
1.5 |
GO:0009644 |
response to high light intensity(GO:0009644) |
| 0.2 |
1.0 |
GO:0033625 |
positive regulation of integrin activation(GO:0033625) |
| 0.2 |
1.0 |
GO:1900104 |
hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.2 |
0.7 |
GO:0032621 |
interleukin-18 production(GO:0032621) |
| 0.2 |
0.5 |
GO:0018879 |
biphenyl metabolic process(GO:0018879) |
| 0.2 |
0.2 |
GO:0031630 |
regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
| 0.2 |
2.4 |
GO:0098967 |
exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 0.2 |
0.7 |
GO:0071376 |
response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.2 |
0.7 |
GO:0098902 |
regulation of membrane depolarization during action potential(GO:0098902) |
| 0.2 |
0.7 |
GO:0070681 |
glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
| 0.2 |
1.9 |
GO:0019885 |
antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
| 0.2 |
3.3 |
GO:0006776 |
vitamin A metabolic process(GO:0006776) |
| 0.2 |
1.7 |
GO:0032049 |
phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin biosynthetic process(GO:0032049) |
| 0.2 |
1.2 |
GO:0090309 |
positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
| 0.2 |
0.5 |
GO:2000583 |
regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000583) negative regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000584) |
| 0.2 |
1.4 |
GO:2000348 |
regulation of CD40 signaling pathway(GO:2000348) |
| 0.2 |
3.0 |
GO:0015732 |
prostaglandin transport(GO:0015732) |
| 0.2 |
0.5 |
GO:0052251 |
induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
| 0.2 |
2.8 |
GO:0001573 |
ganglioside metabolic process(GO:0001573) |
| 0.2 |
0.5 |
GO:0048200 |
COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.2 |
2.1 |
GO:0030497 |
fatty acid elongation(GO:0030497) |
| 0.2 |
0.5 |
GO:0070476 |
RNA (guanine-N7)-methylation(GO:0036265) rRNA (guanine-N7)-methylation(GO:0070476) |
| 0.2 |
0.5 |
GO:0038158 |
granulocyte colony-stimulating factor signaling pathway(GO:0038158) |
| 0.2 |
0.9 |
GO:0009080 |
alanine metabolic process(GO:0006522) alanine catabolic process(GO:0006524) pyruvate family amino acid metabolic process(GO:0009078) pyruvate family amino acid catabolic process(GO:0009080) |
| 0.2 |
0.7 |
GO:0009386 |
translational attenuation(GO:0009386) |
| 0.2 |
0.9 |
GO:0010636 |
positive regulation of mitochondrial fusion(GO:0010636) |
| 0.2 |
0.7 |
GO:0019243 |
methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.2 |
2.1 |
GO:0045542 |
positive regulation of cholesterol biosynthetic process(GO:0045542) |
| 0.2 |
0.9 |
GO:0061073 |
ciliary body morphogenesis(GO:0061073) |
| 0.2 |
1.2 |
GO:0002865 |
negative regulation of acute inflammatory response to antigenic stimulus(GO:0002865) |
| 0.2 |
0.7 |
GO:0045875 |
negative regulation of sister chromatid cohesion(GO:0045875) |
| 0.2 |
1.4 |
GO:0032417 |
positive regulation of sodium:proton antiporter activity(GO:0032417) |
| 0.2 |
1.6 |
GO:0048312 |
intracellular distribution of mitochondria(GO:0048312) |
| 0.2 |
1.4 |
GO:0006689 |
ganglioside catabolic process(GO:0006689) |
| 0.2 |
0.2 |
GO:1903553 |
positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.2 |
3.9 |
GO:0006450 |
regulation of translational fidelity(GO:0006450) |
| 0.2 |
0.9 |
GO:0006049 |
UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.2 |
0.7 |
GO:0070407 |
oxidation-dependent protein catabolic process(GO:0070407) |
| 0.2 |
0.5 |
GO:0071639 |
positive regulation of monocyte chemotactic protein-1 production(GO:0071639) |
| 0.2 |
0.7 |
GO:0015781 |
pyrimidine nucleotide-sugar transport(GO:0015781) |
| 0.2 |
0.7 |
GO:0035281 |
pre-miRNA export from nucleus(GO:0035281) |
| 0.2 |
0.9 |
GO:0021773 |
striatal medium spiny neuron differentiation(GO:0021773) |
| 0.2 |
1.8 |
GO:0060075 |
regulation of resting membrane potential(GO:0060075) |
| 0.2 |
1.3 |
GO:0044791 |
modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
| 0.2 |
2.2 |
GO:0060125 |
negative regulation of growth hormone secretion(GO:0060125) |
| 0.2 |
0.4 |
GO:0070054 |
mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response(GO:0030969) mRNA splicing, via endonucleolytic cleavage and ligation(GO:0070054) mRNA endonucleolytic cleavage involved in unfolded protein response(GO:0070055) |
| 0.2 |
0.7 |
GO:0009111 |
vitamin catabolic process(GO:0009111) |
| 0.2 |
1.8 |
GO:0042023 |
DNA endoreduplication(GO:0042023) |
| 0.2 |
0.7 |
GO:1901301 |
regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 0.2 |
1.1 |
GO:1990164 |
histone H2A phosphorylation(GO:1990164) |
| 0.2 |
0.9 |
GO:2000660 |
negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
| 0.2 |
0.4 |
GO:0046271 |
phenylpropanoid catabolic process(GO:0046271) |
| 0.2 |
0.4 |
GO:0061198 |
fungiform papilla formation(GO:0061198) |
| 0.2 |
5.8 |
GO:0006490 |
oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
| 0.2 |
1.1 |
GO:2000288 |
positive regulation of myoblast proliferation(GO:2000288) |
| 0.2 |
2.0 |
GO:0051599 |
response to hydrostatic pressure(GO:0051599) |
| 0.2 |
0.2 |
GO:1902202 |
regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
| 0.2 |
4.4 |
GO:0034975 |
protein folding in endoplasmic reticulum(GO:0034975) |
| 0.2 |
2.0 |
GO:0090091 |
positive regulation of extracellular matrix disassembly(GO:0090091) |
| 0.2 |
0.9 |
GO:0009436 |
glyoxylate catabolic process(GO:0009436) |
| 0.2 |
1.3 |
GO:0003228 |
atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
| 0.2 |
2.0 |
GO:1904352 |
positive regulation of protein catabolic process in the vacuole(GO:1904352) |
| 0.2 |
0.9 |
GO:0035672 |
oligopeptide transmembrane transport(GO:0035672) |
| 0.2 |
1.1 |
GO:0002911 |
lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
| 0.2 |
2.2 |
GO:0032927 |
positive regulation of activin receptor signaling pathway(GO:0032927) |
| 0.2 |
2.0 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.2 |
1.3 |
GO:1903659 |
regulation of complement-dependent cytotoxicity(GO:1903659) |
| 0.2 |
1.1 |
GO:1904996 |
positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
| 0.2 |
0.4 |
GO:0072429 |
response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.2 |
2.0 |
GO:0007042 |
lysosomal lumen acidification(GO:0007042) |
| 0.2 |
0.4 |
GO:0090611 |
ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
| 0.2 |
0.7 |
GO:0051464 |
positive regulation of cortisol secretion(GO:0051464) |
| 0.2 |
0.7 |
GO:0034729 |
histone H3-K79 methylation(GO:0034729) |
| 0.2 |
1.1 |
GO:0051574 |
positive regulation of histone H3-K9 methylation(GO:0051574) |
| 0.2 |
3.2 |
GO:0002544 |
chronic inflammatory response(GO:0002544) |
| 0.2 |
0.2 |
GO:0031585 |
regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
| 0.2 |
1.5 |
GO:0097411 |
hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.2 |
0.2 |
GO:0070172 |
positive regulation of tooth mineralization(GO:0070172) |
| 0.2 |
0.6 |
GO:0070625 |
zymogen granule exocytosis(GO:0070625) |
| 0.2 |
1.7 |
GO:0042492 |
gamma-delta T cell differentiation(GO:0042492) |
| 0.2 |
1.7 |
GO:0046654 |
tetrahydrofolate biosynthetic process(GO:0046654) |
| 0.2 |
0.2 |
GO:1903895 |
negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
| 0.2 |
0.2 |
GO:0016321 |
female meiosis chromosome segregation(GO:0016321) |
| 0.2 |
0.6 |
GO:0019858 |
cytosine metabolic process(GO:0019858) |
| 0.2 |
0.2 |
GO:0050653 |
chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
| 0.2 |
1.9 |
GO:0060670 |
branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.2 |
0.6 |
GO:0060168 |
positive regulation of adenosine receptor signaling pathway(GO:0060168) |
| 0.2 |
1.3 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 0.2 |
0.2 |
GO:2000819 |
regulation of nucleotide-excision repair(GO:2000819) |
| 0.2 |
3.1 |
GO:0046033 |
AMP metabolic process(GO:0046033) |
| 0.2 |
0.6 |
GO:0001188 |
RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
| 0.2 |
0.6 |
GO:0044828 |
negative regulation by host of viral genome replication(GO:0044828) |
| 0.2 |
1.0 |
GO:0061343 |
cell adhesion involved in heart morphogenesis(GO:0061343) |
| 0.2 |
3.5 |
GO:0015871 |
choline transport(GO:0015871) |
| 0.2 |
1.0 |
GO:0071400 |
cellular response to oleic acid(GO:0071400) |
| 0.2 |
0.2 |
GO:0072137 |
condensed mesenchymal cell proliferation(GO:0072137) |
| 0.2 |
2.7 |
GO:0042407 |
cristae formation(GO:0042407) |
| 0.2 |
2.3 |
GO:0061029 |
eyelid development in camera-type eye(GO:0061029) |
| 0.2 |
1.0 |
GO:0051084 |
'de novo' posttranslational protein folding(GO:0051084) |
| 0.2 |
2.3 |
GO:2001256 |
regulation of store-operated calcium entry(GO:2001256) |
| 0.2 |
1.9 |
GO:0097491 |
sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
| 0.2 |
0.2 |
GO:1904933 |
regulation of cell proliferation in midbrain(GO:1904933) |
| 0.2 |
6.8 |
GO:0015012 |
heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
| 0.2 |
0.6 |
GO:1902528 |
regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 0.2 |
0.4 |
GO:0014063 |
negative regulation of serotonin secretion(GO:0014063) |
| 0.2 |
0.6 |
GO:0036046 |
protein demalonylation(GO:0036046) peptidyl-lysine demalonylation(GO:0036047) protein desuccinylation(GO:0036048) peptidyl-lysine desuccinylation(GO:0036049) protein deglutarylation(GO:0061698) peptidyl-lysine deglutarylation(GO:0061699) |
| 0.2 |
1.0 |
GO:0006537 |
glutamate biosynthetic process(GO:0006537) |
| 0.2 |
2.2 |
GO:0034398 |
telomere tethering at nuclear periphery(GO:0034398) meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
| 0.2 |
1.4 |
GO:0016139 |
glycoside catabolic process(GO:0016139) |
| 0.2 |
1.8 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) |
| 0.2 |
1.2 |
GO:0071051 |
polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
| 0.2 |
0.6 |
GO:2000327 |
regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
| 0.2 |
0.4 |
GO:0030656 |
regulation of vitamin metabolic process(GO:0030656) |
| 0.2 |
2.6 |
GO:0097503 |
sialylation(GO:0097503) |
| 0.2 |
0.2 |
GO:0034140 |
negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
| 0.2 |
0.8 |
GO:0046900 |
tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.2 |
0.8 |
GO:0070889 |
platelet alpha granule organization(GO:0070889) |
| 0.2 |
0.6 |
GO:0072387 |
flavin adenine dinucleotide metabolic process(GO:0072387) |
| 0.2 |
1.8 |
GO:1902866 |
regulation of retina development in camera-type eye(GO:1902866) |
| 0.2 |
0.8 |
GO:1904117 |
response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
| 0.2 |
0.4 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.2 |
0.8 |
GO:0018242 |
protein O-linked glycosylation via serine(GO:0018242) |
| 0.2 |
0.6 |
GO:0060179 |
male mating behavior(GO:0060179) |
| 0.2 |
1.2 |
GO:0061737 |
leukotriene signaling pathway(GO:0061737) |
| 0.2 |
0.2 |
GO:0000055 |
ribosomal large subunit export from nucleus(GO:0000055) |
| 0.2 |
1.2 |
GO:0015842 |
aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
| 0.2 |
1.4 |
GO:2000042 |
negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 0.2 |
2.3 |
GO:0006684 |
sphingomyelin metabolic process(GO:0006684) |
| 0.2 |
3.1 |
GO:0042554 |
superoxide anion generation(GO:0042554) |
| 0.2 |
0.8 |
GO:0030037 |
actin filament reorganization involved in cell cycle(GO:0030037) |
| 0.2 |
2.1 |
GO:0007076 |
mitotic chromosome condensation(GO:0007076) |
| 0.2 |
0.6 |
GO:0006781 |
succinyl-CoA pathway(GO:0006781) |
| 0.2 |
1.2 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 0.2 |
0.4 |
GO:0008593 |
regulation of Notch signaling pathway(GO:0008593) |
| 0.2 |
0.8 |
GO:0036100 |
leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
| 0.2 |
0.6 |
GO:2000616 |
negative regulation of histone H3-K9 acetylation(GO:2000616) |
| 0.2 |
0.4 |
GO:1904851 |
regulation of establishment of protein localization to telomere(GO:0070203) positive regulation of establishment of protein localization to telomere(GO:1904851) |
| 0.2 |
0.6 |
GO:0039019 |
pronephric nephron development(GO:0039019) |
| 0.2 |
0.8 |
GO:0090245 |
axis elongation involved in somitogenesis(GO:0090245) |
| 0.2 |
1.0 |
GO:2001295 |
malonyl-CoA biosynthetic process(GO:2001295) |
| 0.2 |
0.8 |
GO:0006272 |
leading strand elongation(GO:0006272) |
| 0.2 |
2.5 |
GO:1900029 |
positive regulation of ruffle assembly(GO:1900029) |
| 0.2 |
2.1 |
GO:1900112 |
regulation of histone H3-K9 trimethylation(GO:1900112) |
| 0.2 |
0.4 |
GO:0046601 |
positive regulation of centriole replication(GO:0046601) |
| 0.2 |
1.1 |
GO:0033274 |
response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.2 |
0.6 |
GO:1904338 |
regulation of dopaminergic neuron differentiation(GO:1904338) |
| 0.2 |
1.3 |
GO:0039536 |
negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.2 |
0.2 |
GO:0032911 |
negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.2 |
0.9 |
GO:0021943 |
formation of radial glial scaffolds(GO:0021943) |
| 0.2 |
0.9 |
GO:0000379 |
tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.2 |
0.4 |
GO:0002071 |
glandular epithelial cell maturation(GO:0002071) |
| 0.2 |
0.6 |
GO:0070352 |
positive regulation of white fat cell proliferation(GO:0070352) |
| 0.2 |
1.3 |
GO:0098814 |
spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
| 0.2 |
0.6 |
GO:2000491 |
positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.2 |
1.3 |
GO:0015793 |
glycerol transport(GO:0015793) |
| 0.2 |
2.8 |
GO:0035247 |
peptidyl-arginine omega-N-methylation(GO:0035247) |
| 0.2 |
0.6 |
GO:0072178 |
nephric duct morphogenesis(GO:0072178) |
| 0.2 |
0.7 |
GO:0009624 |
response to nematode(GO:0009624) |
| 0.2 |
0.2 |
GO:0072425 |
signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
| 0.2 |
1.3 |
GO:0000183 |
chromatin silencing at rDNA(GO:0000183) |
| 0.2 |
0.6 |
GO:1901254 |
modulation by host of viral RNA genome replication(GO:0044830) positive regulation of intracellular transport of viral material(GO:1901254) |
| 0.2 |
0.7 |
GO:0010286 |
heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
| 0.2 |
0.2 |
GO:0002726 |
positive regulation of T cell cytokine production(GO:0002726) |
| 0.2 |
1.3 |
GO:0032713 |
negative regulation of interleukin-4 production(GO:0032713) |
| 0.2 |
0.7 |
GO:0000972 |
transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
| 0.2 |
0.7 |
GO:0046391 |
5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.2 |
0.6 |
GO:0031508 |
pericentric heterochromatin assembly(GO:0031508) |
| 0.2 |
0.7 |
GO:0043382 |
positive regulation of memory T cell differentiation(GO:0043382) |
| 0.2 |
0.5 |
GO:1903677 |
regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.2 |
1.8 |
GO:0009415 |
response to water(GO:0009415) |
| 0.2 |
1.3 |
GO:0010578 |
regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
| 0.2 |
2.2 |
GO:0003374 |
dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
| 0.2 |
0.7 |
GO:0032329 |
serine transport(GO:0032329) |
| 0.2 |
0.2 |
GO:0071880 |
adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
| 0.2 |
0.2 |
GO:2000506 |
negative regulation of energy homeostasis(GO:2000506) |
| 0.2 |
2.7 |
GO:0090036 |
regulation of protein kinase C signaling(GO:0090036) |
| 0.2 |
2.3 |
GO:0045162 |
clustering of voltage-gated sodium channels(GO:0045162) |
| 0.2 |
0.5 |
GO:0002408 |
myeloid dendritic cell chemotaxis(GO:0002408) |
| 0.2 |
0.5 |
GO:1902365 |
regulation of spindle elongation(GO:0032887) regulation of mitotic spindle elongation(GO:0032888) anastral spindle assembly(GO:0055048) protein localization to spindle pole body(GO:0071988) regulation of protein localization to spindle pole body(GO:1902363) positive regulation of protein localization to spindle pole body(GO:1902365) positive regulation of mitotic spindle elongation(GO:1902846) |
| 0.2 |
0.2 |
GO:0061668 |
mitochondrial ribosome assembly(GO:0061668) |
| 0.2 |
0.5 |
GO:2000418 |
positive regulation of eosinophil migration(GO:2000418) |
| 0.2 |
1.1 |
GO:0036152 |
phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
| 0.2 |
0.7 |
GO:0016078 |
tRNA catabolic process(GO:0016078) |
| 0.2 |
0.5 |
GO:0035048 |
splicing factor protein import into nucleus(GO:0035048) |
| 0.2 |
1.2 |
GO:0010533 |
regulation of activation of Janus kinase activity(GO:0010533) |
| 0.2 |
0.7 |
GO:1901299 |
negative regulation of hydrogen peroxide-mediated programmed cell death(GO:1901299) |
| 0.2 |
2.8 |
GO:0030046 |
parallel actin filament bundle assembly(GO:0030046) |
| 0.2 |
0.7 |
GO:0090669 |
telomerase RNA stabilization(GO:0090669) |
| 0.2 |
6.0 |
GO:0030488 |
tRNA methylation(GO:0030488) |
| 0.2 |
1.6 |
GO:0071578 |
zinc II ion transmembrane import(GO:0071578) |
| 0.2 |
0.2 |
GO:0060648 |
mammary gland bud morphogenesis(GO:0060648) |
| 0.2 |
0.7 |
GO:0036378 |
calcitriol biosynthetic process from calciol(GO:0036378) |
| 0.2 |
0.5 |
GO:0071321 |
cellular response to cGMP(GO:0071321) |
| 0.2 |
1.4 |
GO:1902031 |
regulation of NADP metabolic process(GO:1902031) |
| 0.2 |
0.7 |
GO:1903232 |
melanosome assembly(GO:1903232) |
| 0.2 |
0.9 |
GO:1903630 |
regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
| 0.2 |
0.5 |
GO:0018315 |
molybdenum incorporation into molybdenum-molybdopterin complex(GO:0018315) metal incorporation into metallo-molybdopterin complex(GO:0042040) glycine receptor clustering(GO:0072579) |
| 0.2 |
4.9 |
GO:0001913 |
T cell mediated cytotoxicity(GO:0001913) |
| 0.2 |
0.5 |
GO:0010387 |
COP9 signalosome assembly(GO:0010387) |
| 0.2 |
1.2 |
GO:0035726 |
common myeloid progenitor cell proliferation(GO:0035726) |
| 0.2 |
1.7 |
GO:1901409 |
positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
| 0.2 |
0.3 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 0.2 |
7.5 |
GO:0051602 |
response to electrical stimulus(GO:0051602) |
| 0.2 |
3.6 |
GO:0007216 |
G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.2 |
0.8 |
GO:1901350 |
cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
| 0.2 |
0.5 |
GO:0071504 |
cellular response to heparin(GO:0071504) |
| 0.2 |
0.2 |
GO:0097477 |
lateral motor column neuron migration(GO:0097477) |
| 0.2 |
0.3 |
GO:0038170 |
somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 0.2 |
0.2 |
GO:1904000 |
positive regulation of eating behavior(GO:1904000) regulation of small intestine smooth muscle contraction(GO:1904347) positive regulation of small intestine smooth muscle contraction(GO:1904349) small intestine smooth muscle contraction(GO:1990770) |
| 0.2 |
0.3 |
GO:0018171 |
peptidyl-cysteine oxidation(GO:0018171) |
| 0.2 |
0.7 |
GO:0007000 |
nucleolus organization(GO:0007000) |
| 0.2 |
0.3 |
GO:0000154 |
rRNA modification(GO:0000154) |
| 0.2 |
1.3 |
GO:0033169 |
histone H3-K9 demethylation(GO:0033169) |
| 0.2 |
2.7 |
GO:2000052 |
positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
| 0.2 |
0.3 |
GO:0040031 |
snRNA modification(GO:0040031) |
| 0.2 |
2.2 |
GO:0007016 |
cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.2 |
1.0 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.2 |
0.2 |
GO:0051088 |
PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
| 0.2 |
0.3 |
GO:0040038 |
polar body extrusion after meiotic divisions(GO:0040038) |
| 0.2 |
0.7 |
GO:0061101 |
neuroendocrine cell differentiation(GO:0061101) |
| 0.2 |
0.5 |
GO:0003406 |
retinal pigment epithelium development(GO:0003406) |
| 0.2 |
0.2 |
GO:2000010 |
positive regulation of protein localization to cell surface(GO:2000010) |
| 0.2 |
0.6 |
GO:1900245 |
positive regulation of MDA-5 signaling pathway(GO:1900245) |
| 0.2 |
0.5 |
GO:0061304 |
retinal blood vessel morphogenesis(GO:0061304) |
| 0.2 |
0.3 |
GO:0002101 |
tRNA wobble cytosine modification(GO:0002101) |
| 0.2 |
0.5 |
GO:0051754 |
meiotic sister chromatid cohesion, centromeric(GO:0051754) |
| 0.2 |
0.5 |
GO:1903774 |
positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 0.2 |
0.2 |
GO:0045763 |
negative regulation of cellular amino acid metabolic process(GO:0045763) |
| 0.2 |
0.6 |
GO:0070127 |
tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.2 |
0.6 |
GO:0060363 |
cranial suture morphogenesis(GO:0060363) |
| 0.2 |
0.5 |
GO:0015993 |
molecular hydrogen transport(GO:0015993) |
| 0.2 |
1.1 |
GO:0071763 |
nuclear membrane organization(GO:0071763) |
| 0.2 |
1.1 |
GO:0035616 |
histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.2 |
3.2 |
GO:0007250 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.2 |
0.5 |
GO:1904816 |
regulation of protein localization to chromosome, telomeric region(GO:1904814) positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
| 0.2 |
0.5 |
GO:0007518 |
myoblast fate determination(GO:0007518) |
| 0.2 |
0.5 |
GO:0048842 |
positive regulation of axon extension involved in axon guidance(GO:0048842) |
| 0.2 |
0.2 |
GO:0075732 |
viral penetration into host nucleus(GO:0075732) multi-organism nuclear import(GO:1902594) |
| 0.2 |
1.7 |
GO:0009304 |
tRNA transcription(GO:0009304) |
| 0.2 |
0.3 |
GO:2001034 |
positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
| 0.2 |
0.8 |
GO:1902455 |
negative regulation of stem cell population maintenance(GO:1902455) |
| 0.2 |
0.8 |
GO:0071372 |
cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
| 0.2 |
0.5 |
GO:0033082 |
regulation of extrathymic T cell differentiation(GO:0033082) sebum secreting cell proliferation(GO:1990654) |
| 0.2 |
1.6 |
GO:0006116 |
NADH oxidation(GO:0006116) |
| 0.2 |
0.6 |
GO:0071955 |
recycling endosome to Golgi transport(GO:0071955) |
| 0.2 |
1.2 |
GO:0085020 |
protein K6-linked ubiquitination(GO:0085020) |
| 0.2 |
3.0 |
GO:0090557 |
establishment of endothelial intestinal barrier(GO:0090557) |
| 0.2 |
1.1 |
GO:0016554 |
cytidine to uridine editing(GO:0016554) |
| 0.2 |
1.1 |
GO:0038165 |
oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.2 |
0.8 |
GO:0072553 |
terminal button organization(GO:0072553) |
| 0.2 |
0.3 |
GO:0000706 |
meiotic DNA double-strand break processing(GO:0000706) |
| 0.2 |
0.6 |
GO:0009786 |
regulation of asymmetric cell division(GO:0009786) |
| 0.2 |
0.5 |
GO:0048254 |
snoRNA localization(GO:0048254) |
| 0.2 |
3.2 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 0.2 |
0.5 |
GO:0090370 |
negative regulation of cholesterol efflux(GO:0090370) |
| 0.2 |
0.3 |
GO:0035425 |
autocrine signaling(GO:0035425) |
| 0.2 |
0.2 |
GO:0098735 |
positive regulation of the force of heart contraction(GO:0098735) |
| 0.2 |
0.6 |
GO:1902172 |
keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
| 0.2 |
0.3 |
GO:0044725 |
chromatin reprogramming in the zygote(GO:0044725) |
| 0.2 |
1.8 |
GO:0002523 |
leukocyte migration involved in inflammatory response(GO:0002523) |
| 0.2 |
0.9 |
GO:0045161 |
neuronal ion channel clustering(GO:0045161) |
| 0.2 |
1.8 |
GO:0046697 |
decidualization(GO:0046697) |
| 0.2 |
0.3 |
GO:0003099 |
positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
| 0.2 |
1.1 |
GO:0070544 |
histone H3-K36 demethylation(GO:0070544) |
| 0.2 |
0.6 |
GO:0060454 |
positive regulation of gastric acid secretion(GO:0060454) |
| 0.2 |
0.9 |
GO:0002191 |
cap-dependent translational initiation(GO:0002191) |
| 0.2 |
0.9 |
GO:1903236 |
regulation of leukocyte tethering or rolling(GO:1903236) |
| 0.2 |
0.8 |
GO:0044827 |
modulation by host of viral genome replication(GO:0044827) |
| 0.2 |
1.2 |
GO:0097012 |
cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 0.1 |
0.4 |
GO:1900738 |
positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
| 0.1 |
0.9 |
GO:0034720 |
histone H3-K4 demethylation(GO:0034720) |
| 0.1 |
0.7 |
GO:0030917 |
midbrain-hindbrain boundary development(GO:0030917) |
| 0.1 |
1.5 |
GO:0000056 |
ribosomal small subunit export from nucleus(GO:0000056) |
| 0.1 |
1.3 |
GO:0031936 |
negative regulation of chromatin silencing(GO:0031936) |
| 0.1 |
0.4 |
GO:0030327 |
prenylated protein catabolic process(GO:0030327) |
| 0.1 |
0.9 |
GO:0070475 |
rRNA base methylation(GO:0070475) |
| 0.1 |
0.6 |
GO:1902570 |
protein localization to nucleolus(GO:1902570) |
| 0.1 |
0.3 |
GO:0009106 |
lipoate metabolic process(GO:0009106) |
| 0.1 |
0.9 |
GO:0033152 |
immunoglobulin V(D)J recombination(GO:0033152) |
| 0.1 |
0.6 |
GO:0060480 |
lung goblet cell differentiation(GO:0060480) |
| 0.1 |
0.7 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 0.1 |
0.1 |
GO:0006477 |
protein sulfation(GO:0006477) |
| 0.1 |
0.4 |
GO:0035627 |
ceramide transport(GO:0035627) |
| 0.1 |
0.6 |
GO:0072156 |
distal tubule morphogenesis(GO:0072156) |
| 0.1 |
4.7 |
GO:0018146 |
keratan sulfate biosynthetic process(GO:0018146) |
| 0.1 |
1.5 |
GO:1904322 |
response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.1 |
0.1 |
GO:0002606 |
positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
| 0.1 |
0.4 |
GO:1905232 |
cellular response to L-glutamate(GO:1905232) |
| 0.1 |
0.7 |
GO:0009098 |
branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
| 0.1 |
0.4 |
GO:0071449 |
cellular response to lipid hydroperoxide(GO:0071449) |
| 0.1 |
0.6 |
GO:0006189 |
'de novo' IMP biosynthetic process(GO:0006189) |
| 0.1 |
4.6 |
GO:0070286 |
axonemal dynein complex assembly(GO:0070286) |
| 0.1 |
0.1 |
GO:0045799 |
positive regulation of chromatin assembly or disassembly(GO:0045799) |
| 0.1 |
1.1 |
GO:0015811 |
L-cystine transport(GO:0015811) |
| 0.1 |
0.3 |
GO:0086021 |
SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) |
| 0.1 |
0.9 |
GO:0030174 |
regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.1 |
0.1 |
GO:0010730 |
negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
| 0.1 |
0.8 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
| 0.1 |
0.3 |
GO:1901978 |
positive regulation of cell cycle checkpoint(GO:1901978) |
| 0.1 |
0.4 |
GO:0097475 |
motor neuron migration(GO:0097475) |
| 0.1 |
1.1 |
GO:0010715 |
regulation of extracellular matrix disassembly(GO:0010715) |
| 0.1 |
0.6 |
GO:0016256 |
N-glycan processing to lysosome(GO:0016256) |
| 0.1 |
0.1 |
GO:0007161 |
calcium-independent cell-matrix adhesion(GO:0007161) |
| 0.1 |
1.7 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 0.1 |
0.6 |
GO:1902416 |
positive regulation of mRNA binding(GO:1902416) |
| 0.1 |
1.5 |
GO:0030948 |
negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.1 |
1.1 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.1 |
1.7 |
GO:0097186 |
amelogenesis(GO:0097186) |
| 0.1 |
0.6 |
GO:0046166 |
glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.1 |
0.4 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 0.1 |
0.3 |
GO:0097623 |
potassium ion export across plasma membrane(GO:0097623) |
| 0.1 |
0.3 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.1 |
1.4 |
GO:0000479 |
endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
| 0.1 |
0.7 |
GO:0006999 |
nuclear pore organization(GO:0006999) |
| 0.1 |
3.1 |
GO:0019511 |
peptidyl-proline hydroxylation(GO:0019511) |
| 0.1 |
0.5 |
GO:0071630 |
nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
| 0.1 |
0.1 |
GO:0061744 |
motor behavior(GO:0061744) |
| 0.1 |
0.4 |
GO:0071962 |
mitotic sister chromatid cohesion, centromeric(GO:0071962) |
| 0.1 |
0.3 |
GO:0071169 |
establishment of protein localization to chromatin(GO:0071169) |
| 0.1 |
0.5 |
GO:0033133 |
positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.1 |
3.9 |
GO:0045747 |
positive regulation of Notch signaling pathway(GO:0045747) |
| 0.1 |
0.4 |
GO:0060931 |
sinoatrial node cell development(GO:0060931) |
| 0.1 |
2.3 |
GO:0060022 |
hard palate development(GO:0060022) |
| 0.1 |
1.5 |
GO:0043923 |
positive regulation by host of viral transcription(GO:0043923) |
| 0.1 |
0.3 |
GO:0034769 |
basement membrane disassembly(GO:0034769) |
| 0.1 |
0.4 |
GO:0010607 |
negative regulation of cytoplasmic mRNA processing body assembly(GO:0010607) |
| 0.1 |
1.3 |
GO:0060372 |
regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) |
| 0.1 |
0.1 |
GO:1903625 |
negative regulation of DNA catabolic process(GO:1903625) |
| 0.1 |
0.1 |
GO:0072076 |
nephrogenic mesenchyme development(GO:0072076) |
| 0.1 |
0.5 |
GO:0032581 |
ER-dependent peroxisome organization(GO:0032581) |
| 0.1 |
0.4 |
GO:0060391 |
positive regulation of SMAD protein import into nucleus(GO:0060391) |
| 0.1 |
2.0 |
GO:0034501 |
protein localization to kinetochore(GO:0034501) |
| 0.1 |
0.3 |
GO:0042270 |
protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 0.1 |
0.7 |
GO:0021603 |
cranial nerve formation(GO:0021603) |
| 0.1 |
0.9 |
GO:1904948 |
midbrain dopaminergic neuron differentiation(GO:1904948) |
| 0.1 |
0.4 |
GO:0061724 |
epidermal growth factor catabolic process(GO:0007174) lipophagy(GO:0061724) negative regulation of exosomal secretion(GO:1903542) |
| 0.1 |
0.4 |
GO:0070078 |
peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine(GO:0018395) histone arginine demethylation(GO:0070077) histone H3-R2 demethylation(GO:0070078) histone H4-R3 demethylation(GO:0070079) |
| 0.1 |
0.4 |
GO:0006532 |
aspartate biosynthetic process(GO:0006532) |
| 0.1 |
0.1 |
GO:0051133 |
regulation of NK T cell activation(GO:0051133) |
| 0.1 |
0.8 |
GO:2000773 |
negative regulation of cellular senescence(GO:2000773) |
| 0.1 |
0.6 |
GO:0032494 |
response to peptidoglycan(GO:0032494) |
| 0.1 |
4.6 |
GO:0006656 |
phosphatidylcholine biosynthetic process(GO:0006656) |
| 0.1 |
0.1 |
GO:2000969 |
positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
| 0.1 |
4.1 |
GO:0032527 |
protein exit from endoplasmic reticulum(GO:0032527) |
| 0.1 |
0.5 |
GO:1901097 |
negative regulation of autophagosome maturation(GO:1901097) |
| 0.1 |
0.1 |
GO:1990641 |
response to iron ion starvation(GO:1990641) |
| 0.1 |
1.0 |
GO:0033085 |
negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
| 0.1 |
0.8 |
GO:0035881 |
amacrine cell differentiation(GO:0035881) |
| 0.1 |
0.9 |
GO:0021683 |
cerebellar granular layer morphogenesis(GO:0021683) |
| 0.1 |
1.9 |
GO:0071481 |
cellular response to X-ray(GO:0071481) |
| 0.1 |
1.5 |
GO:0006265 |
DNA topological change(GO:0006265) |
| 0.1 |
1.7 |
GO:0006703 |
estrogen biosynthetic process(GO:0006703) |
| 0.1 |
0.5 |
GO:0086091 |
regulation of heart rate by cardiac conduction(GO:0086091) |
| 0.1 |
0.6 |
GO:1990928 |
response to amino acid starvation(GO:1990928) |
| 0.1 |
3.2 |
GO:0051031 |
tRNA transport(GO:0051031) |
| 0.1 |
1.0 |
GO:2001206 |
positive regulation of osteoclast development(GO:2001206) |
| 0.1 |
0.4 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
| 0.1 |
0.3 |
GO:0017085 |
response to insecticide(GO:0017085) |
| 0.1 |
1.8 |
GO:1990416 |
cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
| 0.1 |
0.5 |
GO:0001555 |
oocyte growth(GO:0001555) |
| 0.1 |
0.6 |
GO:0050482 |
arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
| 0.1 |
0.2 |
GO:1904744 |
positive regulation of telomeric DNA binding(GO:1904744) |
| 0.1 |
0.2 |
GO:0071733 |
regulation of primitive erythrocyte differentiation(GO:0010725) eosinophil fate commitment(GO:0035854) transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
| 0.1 |
0.2 |
GO:2000374 |
regulation of oxygen metabolic process(GO:2000374) |
| 0.1 |
0.4 |
GO:0002818 |
intracellular defense response(GO:0002818) |
| 0.1 |
1.4 |
GO:0086016 |
AV node cell action potential(GO:0086016) AV node cell to bundle of His cell signaling(GO:0086027) |
| 0.1 |
1.2 |
GO:0044341 |
sodium-dependent phosphate transport(GO:0044341) |
| 0.1 |
2.7 |
GO:0042572 |
retinol metabolic process(GO:0042572) |
| 0.1 |
0.1 |
GO:1903551 |
regulation of extracellular exosome assembly(GO:1903551) |
| 0.1 |
0.2 |
GO:0031291 |
Ran protein signal transduction(GO:0031291) |
| 0.1 |
0.2 |
GO:0033184 |
positive regulation of histone ubiquitination(GO:0033184) regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
| 0.1 |
0.5 |
GO:0006857 |
oligopeptide transport(GO:0006857) |
| 0.1 |
0.1 |
GO:0007113 |
endomitotic cell cycle(GO:0007113) |
| 0.1 |
0.7 |
GO:1903690 |
negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.1 |
0.4 |
GO:0046603 |
negative regulation of mitotic centrosome separation(GO:0046603) |
| 0.1 |
0.1 |
GO:0034699 |
response to luteinizing hormone(GO:0034699) |
| 0.1 |
0.1 |
GO:0046338 |
phosphatidylethanolamine catabolic process(GO:0046338) |
| 0.1 |
0.2 |
GO:0035246 |
peptidyl-arginine N-methylation(GO:0035246) |
| 0.1 |
0.5 |
GO:0006990 |
positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 0.1 |
0.1 |
GO:0032275 |
luteinizing hormone secretion(GO:0032275) testosterone secretion(GO:0035936) regulation of testosterone secretion(GO:2000843) positive regulation of testosterone secretion(GO:2000845) |
| 0.1 |
1.6 |
GO:0075522 |
IRES-dependent viral translational initiation(GO:0075522) |
| 0.1 |
0.4 |
GO:0000711 |
meiotic DNA repair synthesis(GO:0000711) |
| 0.1 |
0.4 |
GO:1902410 |
mitotic cytokinetic process(GO:1902410) |
| 0.1 |
0.1 |
GO:0061152 |
trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
| 0.1 |
1.1 |
GO:0010890 |
positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.1 |
0.7 |
GO:0060019 |
radial glial cell differentiation(GO:0060019) |
| 0.1 |
0.7 |
GO:1902902 |
negative regulation of autophagosome assembly(GO:1902902) |
| 0.1 |
0.4 |
GO:0006701 |
progesterone biosynthetic process(GO:0006701) |
| 0.1 |
1.1 |
GO:0002281 |
macrophage activation involved in immune response(GO:0002281) |
| 0.1 |
0.6 |
GO:0019064 |
fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 0.1 |
0.2 |
GO:0006710 |
androgen catabolic process(GO:0006710) |
| 0.1 |
0.3 |
GO:0038043 |
interleukin-5-mediated signaling pathway(GO:0038043) |
| 0.1 |
1.0 |
GO:0007207 |
phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
| 0.1 |
0.7 |
GO:0072348 |
sulfur compound transport(GO:0072348) |
| 0.1 |
0.9 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.1 |
1.8 |
GO:0010663 |
positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.1 |
0.3 |
GO:0030573 |
bile acid catabolic process(GO:0030573) |
| 0.1 |
1.0 |
GO:0006268 |
DNA unwinding involved in DNA replication(GO:0006268) |
| 0.1 |
0.8 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.1 |
1.5 |
GO:0031167 |
rRNA methylation(GO:0031167) |
| 0.1 |
0.6 |
GO:0093001 |
glycolysis from storage polysaccharide through glucose-1-phosphate(GO:0093001) |
| 0.1 |
1.2 |
GO:0032688 |
negative regulation of interferon-beta production(GO:0032688) |
| 0.1 |
0.3 |
GO:0050968 |
detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
| 0.1 |
0.2 |
GO:0033031 |
positive regulation of neutrophil apoptotic process(GO:0033031) |
| 0.1 |
0.6 |
GO:0044027 |
hypermethylation of CpG island(GO:0044027) |
| 0.1 |
0.3 |
GO:0018160 |
peptidyl-pyrromethane cofactor linkage(GO:0018160) |
| 0.1 |
1.2 |
GO:0035092 |
sperm chromatin condensation(GO:0035092) |
| 0.1 |
0.7 |
GO:0021633 |
optic nerve structural organization(GO:0021633) |
| 0.1 |
0.4 |
GO:0002268 |
follicular dendritic cell differentiation(GO:0002268) |
| 0.1 |
0.6 |
GO:0036342 |
post-anal tail morphogenesis(GO:0036342) |
| 0.1 |
0.3 |
GO:0002638 |
negative regulation of immunoglobulin production(GO:0002638) |
| 0.1 |
0.2 |
GO:0090119 |
vesicle-mediated cholesterol transport(GO:0090119) |
| 0.1 |
0.6 |
GO:2001224 |
positive regulation of neuron migration(GO:2001224) |
| 0.1 |
0.2 |
GO:0060481 |
lobar bronchus epithelium development(GO:0060481) |
| 0.1 |
0.5 |
GO:0060717 |
chorion development(GO:0060717) |
| 0.1 |
0.5 |
GO:2000691 |
negative regulation of cardioblast differentiation(GO:0051892) regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
| 0.1 |
0.5 |
GO:0061760 |
antifungal innate immune response(GO:0061760) |
| 0.1 |
1.2 |
GO:0038003 |
opioid receptor signaling pathway(GO:0038003) |
| 0.1 |
0.4 |
GO:0060052 |
neurofilament cytoskeleton organization(GO:0060052) |
| 0.1 |
1.1 |
GO:0045716 |
positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 0.1 |
0.1 |
GO:2000851 |
positive regulation of glucocorticoid secretion(GO:2000851) |
| 0.1 |
0.2 |
GO:1990167 |
protein K27-linked deubiquitination(GO:1990167) |
| 0.1 |
0.2 |
GO:0070365 |
hepatocyte differentiation(GO:0070365) |
| 0.1 |
0.1 |
GO:0072014 |
proximal tubule development(GO:0072014) |
| 0.1 |
0.8 |
GO:0010765 |
positive regulation of sodium ion transport(GO:0010765) |
| 0.1 |
0.6 |
GO:2000468 |
negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) regulation of peroxidase activity(GO:2000468) positive regulation of peroxidase activity(GO:2000470) |
| 0.1 |
0.9 |
GO:0043697 |
dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
| 0.1 |
1.4 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.1 |
0.3 |
GO:0006147 |
guanine catabolic process(GO:0006147) |
| 0.1 |
0.2 |
GO:1903012 |
positive regulation of bone development(GO:1903012) |
| 0.1 |
0.3 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 0.1 |
0.6 |
GO:0090649 |
response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
| 0.1 |
0.3 |
GO:0019732 |
antifungal humoral response(GO:0019732) |
| 0.1 |
0.1 |
GO:0045217 |
cell-cell junction maintenance(GO:0045217) |
| 0.1 |
0.3 |
GO:1904874 |
positive regulation of telomerase RNA localization to Cajal body(GO:1904874) |
| 0.1 |
0.7 |
GO:0006930 |
substrate-dependent cell migration, cell extension(GO:0006930) |
| 0.1 |
0.3 |
GO:0044861 |
protein transport into plasma membrane raft(GO:0044861) |
| 0.1 |
0.4 |
GO:0032328 |
alanine transport(GO:0032328) |
| 0.1 |
1.1 |
GO:0030517 |
negative regulation of axon extension(GO:0030517) |
| 0.1 |
0.6 |
GO:0050916 |
sensory perception of sweet taste(GO:0050916) |
| 0.1 |
1.1 |
GO:1903859 |
regulation of dendrite extension(GO:1903859) |
| 0.1 |
0.1 |
GO:0040033 |
miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.1 |
0.6 |
GO:0015884 |
folic acid transport(GO:0015884) |
| 0.1 |
0.6 |
GO:0051315 |
attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
| 0.1 |
1.1 |
GO:1990573 |
potassium ion import across plasma membrane(GO:1990573) |
| 0.1 |
4.2 |
GO:0030490 |
maturation of SSU-rRNA(GO:0030490) |
| 0.1 |
0.6 |
GO:0006021 |
inositol biosynthetic process(GO:0006021) |
| 0.1 |
0.1 |
GO:0015780 |
nucleotide-sugar transport(GO:0015780) |
| 0.1 |
0.3 |
GO:0050928 |
negative regulation of positive chemotaxis(GO:0050928) |
| 0.1 |
0.3 |
GO:0016098 |
monoterpenoid metabolic process(GO:0016098) |
| 0.1 |
0.3 |
GO:0035279 |
mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
| 0.1 |
0.3 |
GO:1901143 |
insulin catabolic process(GO:1901143) |
| 0.1 |
0.4 |
GO:0002399 |
MHC class II protein complex assembly(GO:0002399) |
| 0.1 |
0.1 |
GO:0097676 |
histone H3-K36 dimethylation(GO:0097676) |
| 0.1 |
0.2 |
GO:0045200 |
establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.1 |
1.4 |
GO:0070886 |
positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.1 |
0.2 |
GO:1903800 |
positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
| 0.1 |
3.9 |
GO:0060216 |
definitive hemopoiesis(GO:0060216) |
| 0.1 |
0.2 |
GO:0090500 |
endocardial cushion to mesenchymal transition(GO:0090500) |
| 0.1 |
1.2 |
GO:0031284 |
positive regulation of guanylate cyclase activity(GO:0031284) |
| 0.1 |
0.2 |
GO:0000393 |
spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
| 0.1 |
0.3 |
GO:0051939 |
gamma-aminobutyric acid import(GO:0051939) |
| 0.1 |
2.1 |
GO:0030322 |
stabilization of membrane potential(GO:0030322) |
| 0.1 |
0.4 |
GO:0030201 |
heparan sulfate proteoglycan metabolic process(GO:0030201) |
| 0.1 |
0.3 |
GO:0061580 |
colon epithelial cell migration(GO:0061580) |
| 0.1 |
0.3 |
GO:1902283 |
negative regulation of primary amine oxidase activity(GO:1902283) |
| 0.1 |
0.8 |
GO:0002430 |
complement receptor mediated signaling pathway(GO:0002430) |
| 0.1 |
0.2 |
GO:0070309 |
lens fiber cell morphogenesis(GO:0070309) |
| 0.1 |
0.2 |
GO:1901895 |
negative regulation of calcium-transporting ATPase activity(GO:1901895) |
| 0.1 |
0.4 |
GO:0032506 |
cytokinetic process(GO:0032506) |
| 0.1 |
1.0 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
| 0.1 |
0.3 |
GO:0032826 |
natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
| 0.1 |
0.6 |
GO:1990776 |
response to angiotensin(GO:1990776) |
| 0.1 |
2.1 |
GO:0045746 |
negative regulation of Notch signaling pathway(GO:0045746) |
| 0.1 |
0.4 |
GO:2000291 |
regulation of myoblast proliferation(GO:2000291) |
| 0.1 |
0.3 |
GO:1904970 |
brush border assembly(GO:1904970) |
| 0.1 |
0.2 |
GO:0048539 |
bone marrow development(GO:0048539) |
| 0.1 |
0.5 |
GO:0043650 |
dicarboxylic acid biosynthetic process(GO:0043650) |
| 0.1 |
0.5 |
GO:0051792 |
medium-chain fatty acid biosynthetic process(GO:0051792) |
| 0.1 |
0.2 |
GO:0002580 |
regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002580) |
| 0.1 |
1.4 |
GO:0000076 |
DNA replication checkpoint(GO:0000076) |
| 0.1 |
0.8 |
GO:0060244 |
negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 0.1 |
0.4 |
GO:0007039 |
protein catabolic process in the vacuole(GO:0007039) |
| 0.1 |
0.3 |
GO:0002933 |
lipid hydroxylation(GO:0002933) |
| 0.1 |
1.3 |
GO:0018206 |
peptidyl-methionine modification(GO:0018206) |
| 0.1 |
3.2 |
GO:0010738 |
regulation of protein kinase A signaling(GO:0010738) |
| 0.1 |
0.6 |
GO:0032287 |
peripheral nervous system myelin maintenance(GO:0032287) |
| 0.1 |
0.7 |
GO:0001833 |
inner cell mass cell proliferation(GO:0001833) |
| 0.1 |
1.7 |
GO:0006400 |
tRNA modification(GO:0006400) |
| 0.1 |
0.8 |
GO:0050957 |
equilibrioception(GO:0050957) |
| 0.1 |
0.1 |
GO:0046931 |
pore complex assembly(GO:0046931) |
| 0.1 |
0.1 |
GO:0060913 |
cardiac cell fate determination(GO:0060913) |
| 0.1 |
1.7 |
GO:0051310 |
metaphase plate congression(GO:0051310) |
| 0.1 |
1.6 |
GO:0001522 |
pseudouridine synthesis(GO:0001522) |
| 0.1 |
0.3 |
GO:1900226 |
negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
| 0.1 |
1.0 |
GO:0001682 |
tRNA 5'-leader removal(GO:0001682) |
| 0.1 |
1.0 |
GO:0006828 |
manganese ion transport(GO:0006828) |
| 0.1 |
0.3 |
GO:0071395 |
response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
| 0.1 |
1.2 |
GO:0071542 |
dopaminergic neuron differentiation(GO:0071542) |
| 0.1 |
0.5 |
GO:0071871 |
response to epinephrine(GO:0071871) |
| 0.1 |
0.5 |
GO:0048715 |
negative regulation of oligodendrocyte differentiation(GO:0048715) |
| 0.1 |
0.5 |
GO:0042340 |
keratan sulfate catabolic process(GO:0042340) |
| 0.1 |
0.9 |
GO:0070933 |
histone H4 deacetylation(GO:0070933) |
| 0.1 |
0.4 |
GO:0071071 |
regulation of phospholipid biosynthetic process(GO:0071071) |
| 0.1 |
0.1 |
GO:0055095 |
lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
| 0.1 |
0.9 |
GO:0042045 |
epithelial fluid transport(GO:0042045) |
| 0.1 |
0.5 |
GO:0072205 |
metanephric collecting duct development(GO:0072205) |
| 0.1 |
1.0 |
GO:0001696 |
gastric acid secretion(GO:0001696) |
| 0.1 |
0.7 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.1 |
0.2 |
GO:0002023 |
reduction of food intake in response to dietary excess(GO:0002023) |
| 0.1 |
0.2 |
GO:1901142 |
insulin metabolic process(GO:1901142) |
| 0.1 |
0.8 |
GO:0098719 |
sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.1 |
0.3 |
GO:0072092 |
ureteric bud invasion(GO:0072092) |
| 0.1 |
0.4 |
GO:0032074 |
negative regulation of nuclease activity(GO:0032074) |
| 0.1 |
0.3 |
GO:0060600 |
dichotomous subdivision of an epithelial terminal unit(GO:0060600) |
| 0.1 |
0.2 |
GO:0045819 |
positive regulation of glycogen catabolic process(GO:0045819) |
| 0.1 |
0.2 |
GO:0060474 |
positive regulation of sperm motility involved in capacitation(GO:0060474) |
| 0.1 |
1.2 |
GO:1902373 |
negative regulation of mRNA catabolic process(GO:1902373) |
| 0.1 |
0.3 |
GO:0051230 |
mitotic spindle disassembly(GO:0051228) spindle disassembly(GO:0051230) |
| 0.1 |
0.1 |
GO:1900193 |
regulation of oocyte maturation(GO:1900193) |
| 0.1 |
3.9 |
GO:2000649 |
regulation of sodium ion transmembrane transporter activity(GO:2000649) |
| 0.1 |
0.5 |
GO:0043117 |
positive regulation of vascular permeability(GO:0043117) |
| 0.1 |
0.3 |
GO:0046010 |
positive regulation of circadian sleep/wake cycle, non-REM sleep(GO:0046010) |
| 0.1 |
0.6 |
GO:0010792 |
DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
| 0.1 |
0.2 |
GO:0000460 |
maturation of 5.8S rRNA(GO:0000460) |
| 0.1 |
2.7 |
GO:0010824 |
regulation of centrosome duplication(GO:0010824) |
| 0.1 |
0.8 |
GO:0002369 |
T cell cytokine production(GO:0002369) |
| 0.1 |
0.3 |
GO:0002296 |
T-helper 1 cell lineage commitment(GO:0002296) |
| 0.1 |
5.0 |
GO:0050909 |
sensory perception of taste(GO:0050909) |
| 0.1 |
2.3 |
GO:0035428 |
hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
| 0.1 |
0.6 |
GO:0090178 |
regulation of establishment of planar polarity involved in neural tube closure(GO:0090178) planar cell polarity pathway involved in neural tube closure(GO:0090179) |
| 0.1 |
1.1 |
GO:0016998 |
cell wall macromolecule catabolic process(GO:0016998) |
| 0.1 |
0.4 |
GO:0019464 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.1 |
1.4 |
GO:0015804 |
neutral amino acid transport(GO:0015804) |
| 0.1 |
1.7 |
GO:0070262 |
peptidyl-serine dephosphorylation(GO:0070262) |
| 0.1 |
0.5 |
GO:0042738 |
exogenous drug catabolic process(GO:0042738) |
| 0.1 |
0.5 |
GO:0001705 |
ectoderm formation(GO:0001705) ectodermal cell fate commitment(GO:0001712) |
| 0.1 |
1.1 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.1 |
0.3 |
GO:1902075 |
cellular response to salt(GO:1902075) |
| 0.1 |
1.2 |
GO:0050812 |
regulation of acyl-CoA biosynthetic process(GO:0050812) |
| 0.1 |
0.2 |
GO:0071422 |
succinate transport(GO:0015744) succinate transmembrane transport(GO:0071422) |
| 0.1 |
0.6 |
GO:0001661 |
conditioned taste aversion(GO:0001661) |
| 0.1 |
0.6 |
GO:0035897 |
proteolysis in other organism(GO:0035897) |
| 0.1 |
0.6 |
GO:0035879 |
plasma membrane lactate transport(GO:0035879) |
| 0.1 |
1.3 |
GO:0009812 |
flavonoid metabolic process(GO:0009812) |
| 0.1 |
0.4 |
GO:0009149 |
pyrimidine nucleoside triphosphate catabolic process(GO:0009149) pyrimidine deoxyribonucleoside triphosphate catabolic process(GO:0009213) |
| 0.1 |
0.2 |
GO:1900019 |
regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
| 0.1 |
0.1 |
GO:0061394 |
regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
| 0.1 |
1.8 |
GO:0034204 |
lipid translocation(GO:0034204) |
| 0.1 |
0.2 |
GO:0019364 |
NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 0.1 |
0.5 |
GO:0014870 |
response to muscle inactivity(GO:0014870) |
| 0.1 |
0.8 |
GO:0044030 |
regulation of DNA methylation(GO:0044030) |
| 0.1 |
0.4 |
GO:1905245 |
regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902959) regulation of aspartic-type peptidase activity(GO:1905245) |
| 0.1 |
0.5 |
GO:0070092 |
glucagon secretion(GO:0070091) regulation of glucagon secretion(GO:0070092) |
| 0.1 |
0.1 |
GO:0042536 |
negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
| 0.1 |
0.2 |
GO:1902080 |
regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) |
| 0.1 |
0.3 |
GO:0018197 |
peptidyl-aspartic acid modification(GO:0018197) peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.1 |
0.5 |
GO:1904779 |
regulation of protein localization to centrosome(GO:1904779) |
| 0.1 |
0.3 |
GO:0018101 |
protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 0.1 |
0.2 |
GO:1901162 |
primary amino compound biosynthetic process(GO:1901162) |
| 0.1 |
0.5 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.1 |
0.1 |
GO:0007060 |
male meiosis chromosome segregation(GO:0007060) |
| 0.1 |
0.3 |
GO:2000741 |
positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
| 0.1 |
0.2 |
GO:2000275 |
regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
| 0.1 |
0.4 |
GO:2000323 |
negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
| 0.1 |
0.7 |
GO:0001893 |
maternal placenta development(GO:0001893) |
| 0.1 |
0.2 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
| 0.1 |
0.1 |
GO:0002183 |
cytoplasmic translational initiation(GO:0002183) |
| 0.1 |
0.4 |
GO:1904526 |
regulation of microtubule binding(GO:1904526) |
| 0.1 |
0.1 |
GO:1903413 |
cellular response to bile acid(GO:1903413) |
| 0.1 |
0.4 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.1 |
0.1 |
GO:0036115 |
fatty-acyl-CoA catabolic process(GO:0036115) |
| 0.1 |
0.4 |
GO:0042573 |
retinoic acid metabolic process(GO:0042573) |
| 0.1 |
0.3 |
GO:0048749 |
compound eye development(GO:0048749) |
| 0.1 |
0.4 |
GO:1901202 |
negative regulation of extracellular matrix assembly(GO:1901202) |
| 0.1 |
0.1 |
GO:0030950 |
establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 0.1 |
0.5 |
GO:0034773 |
histone H4-K20 trimethylation(GO:0034773) |
| 0.1 |
0.7 |
GO:0003084 |
positive regulation of systemic arterial blood pressure(GO:0003084) |
| 0.1 |
0.1 |
GO:0071402 |
cellular response to lipoprotein particle stimulus(GO:0071402) |
| 0.1 |
0.6 |
GO:0032060 |
bleb assembly(GO:0032060) |
| 0.1 |
0.1 |
GO:0021530 |
spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
| 0.1 |
0.8 |
GO:0010457 |
centriole-centriole cohesion(GO:0010457) |
| 0.1 |
0.1 |
GO:2000813 |
negative regulation of barbed-end actin filament capping(GO:2000813) |
| 0.1 |
0.1 |
GO:0071459 |
protein localization to chromosome, centromeric region(GO:0071459) |
| 0.1 |
0.8 |
GO:0000160 |
phosphorelay signal transduction system(GO:0000160) |
| 0.1 |
0.8 |
GO:0043249 |
erythrocyte maturation(GO:0043249) |
| 0.1 |
0.1 |
GO:1901382 |
chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
| 0.1 |
0.3 |
GO:0032484 |
Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
| 0.1 |
0.2 |
GO:0072526 |
pyridine-containing compound catabolic process(GO:0072526) |
| 0.1 |
0.4 |
GO:0010248 |
establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
| 0.1 |
0.5 |
GO:0071985 |
multivesicular body sorting pathway(GO:0071985) |
| 0.1 |
0.6 |
GO:0006506 |
GPI anchor metabolic process(GO:0006505) GPI anchor biosynthetic process(GO:0006506) |
| 0.1 |
0.7 |
GO:0000733 |
DNA strand renaturation(GO:0000733) |
| 0.1 |
0.1 |
GO:0040009 |
regulation of growth rate(GO:0040009) |
| 0.1 |
0.1 |
GO:0003164 |
His-Purkinje system development(GO:0003164) |
| 0.1 |
0.3 |
GO:0030223 |
neutrophil differentiation(GO:0030223) |
| 0.1 |
0.3 |
GO:1990403 |
embryonic brain development(GO:1990403) |
| 0.1 |
3.5 |
GO:0070830 |
bicellular tight junction assembly(GO:0070830) |
| 0.1 |
0.1 |
GO:0000270 |
peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
| 0.1 |
1.1 |
GO:0051601 |
exocyst localization(GO:0051601) |
| 0.1 |
0.8 |
GO:1904714 |
regulation of chaperone-mediated autophagy(GO:1904714) |
| 0.1 |
0.5 |
GO:0097338 |
response to clozapine(GO:0097338) |
| 0.1 |
1.3 |
GO:0010603 |
regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
| 0.1 |
0.3 |
GO:0019343 |
cysteine biosynthetic process via cystathionine(GO:0019343) |
| 0.1 |
0.5 |
GO:0032790 |
ribosome disassembly(GO:0032790) |
| 0.1 |
0.2 |
GO:0019747 |
regulation of isoprenoid metabolic process(GO:0019747) |
| 0.1 |
0.4 |
GO:0080182 |
histone H3-K4 trimethylation(GO:0080182) |
| 0.1 |
0.1 |
GO:0032497 |
detection of lipopolysaccharide(GO:0032497) |
| 0.1 |
0.5 |
GO:0035521 |
monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.1 |
0.1 |
GO:0032229 |
negative regulation of synaptic transmission, GABAergic(GO:0032229) |
| 0.1 |
0.4 |
GO:0032483 |
regulation of Rab protein signal transduction(GO:0032483) |
| 0.1 |
0.1 |
GO:2001023 |
regulation of response to drug(GO:2001023) |
| 0.1 |
1.0 |
GO:0031293 |
membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.1 |
0.5 |
GO:0033151 |
V(D)J recombination(GO:0033151) |
| 0.1 |
0.2 |
GO:0061484 |
hematopoietic stem cell homeostasis(GO:0061484) |
| 0.1 |
0.2 |
GO:0001868 |
regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
| 0.1 |
0.9 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.1 |
0.3 |
GO:0072383 |
plus-end-directed vesicle transport along microtubule(GO:0072383) |
| 0.1 |
0.6 |
GO:0098856 |
intestinal cholesterol absorption(GO:0030299) intestinal lipid absorption(GO:0098856) |
| 0.1 |
0.1 |
GO:0050955 |
thermoception(GO:0050955) |
| 0.1 |
0.6 |
GO:0044110 |
growth involved in symbiotic interaction(GO:0044110) growth of symbiont involved in interaction with host(GO:0044116) |
| 0.1 |
0.1 |
GO:0021764 |
amygdala development(GO:0021764) |
| 0.1 |
3.5 |
GO:0010501 |
RNA secondary structure unwinding(GO:0010501) |
| 0.1 |
0.3 |
GO:0042776 |
mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
| 0.1 |
0.4 |
GO:0032264 |
IMP salvage(GO:0032264) |
| 0.1 |
0.1 |
GO:1902990 |
mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
| 0.1 |
0.2 |
GO:0043474 |
eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
| 0.1 |
0.5 |
GO:0031022 |
nuclear migration along microfilament(GO:0031022) |
| 0.1 |
0.2 |
GO:0042416 |
dopamine biosynthetic process(GO:0042416) |
| 0.1 |
0.4 |
GO:0045876 |
positive regulation of sister chromatid cohesion(GO:0045876) |
| 0.1 |
0.1 |
GO:0031392 |
regulation of prostaglandin biosynthetic process(GO:0031392) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) |
| 0.1 |
0.6 |
GO:0039535 |
regulation of RIG-I signaling pathway(GO:0039535) |
| 0.1 |
0.4 |
GO:0042760 |
very long-chain fatty acid catabolic process(GO:0042760) |
| 0.1 |
9.3 |
GO:0043484 |
regulation of RNA splicing(GO:0043484) |
| 0.1 |
0.1 |
GO:0051890 |
regulation of cardioblast differentiation(GO:0051890) |
| 0.1 |
0.4 |
GO:0035860 |
glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
| 0.1 |
0.5 |
GO:0021591 |
ventricular system development(GO:0021591) |
| 0.1 |
0.1 |
GO:0019240 |
citrulline biosynthetic process(GO:0019240) |
| 0.1 |
0.2 |
GO:0060982 |
coronary artery morphogenesis(GO:0060982) |
| 0.1 |
0.2 |
GO:0038163 |
thrombopoietin-mediated signaling pathway(GO:0038163) |
| 0.1 |
0.1 |
GO:0050925 |
negative regulation of negative chemotaxis(GO:0050925) |
| 0.1 |
0.1 |
GO:0038030 |
non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.1 |
0.5 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 0.1 |
1.0 |
GO:0007130 |
synaptonemal complex assembly(GO:0007130) |
| 0.1 |
0.1 |
GO:1902269 |
positive regulation of polyamine transmembrane transport(GO:1902269) |
| 0.1 |
0.4 |
GO:0001780 |
neutrophil homeostasis(GO:0001780) |
| 0.1 |
0.2 |
GO:0046116 |
queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.1 |
0.1 |
GO:0051799 |
negative regulation of hair follicle development(GO:0051799) |
| 0.1 |
2.3 |
GO:0038128 |
ERBB2 signaling pathway(GO:0038128) |
| 0.1 |
0.8 |
GO:0046602 |
regulation of mitotic centrosome separation(GO:0046602) |
| 0.1 |
0.1 |
GO:0061590 |
calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
| 0.1 |
0.4 |
GO:0038110 |
interleukin-2-mediated signaling pathway(GO:0038110) |
| 0.1 |
1.0 |
GO:0008347 |
glial cell migration(GO:0008347) |
| 0.1 |
0.6 |
GO:0045742 |
positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
| 0.1 |
2.0 |
GO:0003009 |
skeletal muscle contraction(GO:0003009) |
| 0.1 |
0.3 |
GO:0060068 |
vagina development(GO:0060068) |
| 0.1 |
0.5 |
GO:0070970 |
interleukin-2 secretion(GO:0070970) |
| 0.1 |
0.9 |
GO:1902018 |
negative regulation of cilium assembly(GO:1902018) |
| 0.1 |
0.2 |
GO:0090646 |
mitochondrial tRNA processing(GO:0090646) mitochondrial tRNA 3'-end processing(GO:1990180) |
| 0.1 |
0.7 |
GO:0048291 |
isotype switching to IgG isotypes(GO:0048291) |
| 0.1 |
2.4 |
GO:1903779 |
regulation of cardiac conduction(GO:1903779) |
| 0.1 |
0.2 |
GO:0048250 |
mitochondrial iron ion transport(GO:0048250) |
| 0.1 |
2.7 |
GO:0007157 |
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.1 |
0.1 |
GO:1901876 |
regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
| 0.1 |
1.5 |
GO:0090200 |
positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
| 0.1 |
0.2 |
GO:0060385 |
axonogenesis involved in innervation(GO:0060385) |
| 0.1 |
0.1 |
GO:0070898 |
RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
| 0.1 |
0.2 |
GO:0048388 |
endosomal lumen acidification(GO:0048388) |
| 0.1 |
0.7 |
GO:0060689 |
cell differentiation involved in salivary gland development(GO:0060689) |
| 0.1 |
0.5 |
GO:2000253 |
positive regulation of feeding behavior(GO:2000253) |
| 0.1 |
0.6 |
GO:0051964 |
negative regulation of synapse assembly(GO:0051964) |
| 0.1 |
0.1 |
GO:0010360 |
negative regulation of anion channel activity(GO:0010360) |
| 0.1 |
0.1 |
GO:2000617 |
positive regulation of histone H3-K9 acetylation(GO:2000617) |
| 0.1 |
0.3 |
GO:0035610 |
protein side chain deglutamylation(GO:0035610) |
| 0.1 |
0.5 |
GO:1901660 |
calcium ion export(GO:1901660) |
| 0.1 |
0.2 |
GO:0048821 |
erythrocyte development(GO:0048821) |
| 0.1 |
0.1 |
GO:0071034 |
CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
| 0.1 |
0.1 |
GO:0001994 |
norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
| 0.1 |
0.2 |
GO:0070378 |
positive regulation of ERK5 cascade(GO:0070378) |
| 0.1 |
0.4 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 0.1 |
0.1 |
GO:0003408 |
optic cup formation involved in camera-type eye development(GO:0003408) |
| 0.1 |
0.3 |
GO:0016199 |
axon midline choice point recognition(GO:0016199) |
| 0.1 |
0.2 |
GO:0031427 |
response to methotrexate(GO:0031427) |
| 0.1 |
0.2 |
GO:0035330 |
regulation of hippo signaling(GO:0035330) |
| 0.1 |
0.3 |
GO:0016560 |
protein import into peroxisome matrix, docking(GO:0016560) |
| 0.1 |
0.6 |
GO:0070389 |
chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.1 |
0.1 |
GO:0006529 |
asparagine biosynthetic process(GO:0006529) |
| 0.1 |
0.3 |
GO:0035021 |
negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.1 |
0.3 |
GO:0040030 |
regulation of molecular function, epigenetic(GO:0040030) |
| 0.1 |
0.3 |
GO:0072385 |
minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.1 |
0.1 |
GO:0072708 |
response to sorbitol(GO:0072708) |
| 0.1 |
0.1 |
GO:0032224 |
positive regulation of synaptic transmission, cholinergic(GO:0032224) |
| 0.1 |
0.5 |
GO:0021670 |
lateral ventricle development(GO:0021670) |
| 0.1 |
0.2 |
GO:0099538 |
synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
| 0.0 |
0.1 |
GO:0045897 |
positive regulation of transcription during mitosis(GO:0045897) |
| 0.0 |
0.9 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.0 |
0.2 |
GO:1901317 |
regulation of sperm motility(GO:1901317) |
| 0.0 |
0.0 |
GO:0032627 |
interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
| 0.0 |
0.2 |
GO:0043606 |
histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
| 0.0 |
0.0 |
GO:0060462 |
lung lobe development(GO:0060462) lung lobe morphogenesis(GO:0060463) |
| 0.0 |
1.6 |
GO:0000027 |
ribosomal large subunit assembly(GO:0000027) |
| 0.0 |
0.1 |
GO:0090086 |
negative regulation of protein deubiquitination(GO:0090086) |
| 0.0 |
0.4 |
GO:0006627 |
protein processing involved in protein targeting to mitochondrion(GO:0006627) |
| 0.0 |
0.4 |
GO:0016075 |
rRNA catabolic process(GO:0016075) |
| 0.0 |
0.8 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.0 |
0.5 |
GO:0010818 |
T cell chemotaxis(GO:0010818) |
| 0.0 |
0.1 |
GO:0099566 |
regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
| 0.0 |
0.2 |
GO:1902894 |
negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
| 0.0 |
0.2 |
GO:0006238 |
CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
| 0.0 |
0.6 |
GO:0006570 |
tyrosine metabolic process(GO:0006570) |
| 0.0 |
0.4 |
GO:0051415 |
interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.0 |
1.9 |
GO:0044380 |
protein localization to cytoskeleton(GO:0044380) |
| 0.0 |
0.4 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 0.0 |
0.3 |
GO:0018231 |
peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.0 |
0.5 |
GO:0007064 |
mitotic sister chromatid cohesion(GO:0007064) |
| 0.0 |
0.1 |
GO:0030186 |
melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
| 0.0 |
0.2 |
GO:0097026 |
dendritic cell dendrite assembly(GO:0097026) |
| 0.0 |
0.1 |
GO:0033563 |
dorsal/ventral axon guidance(GO:0033563) |
| 0.0 |
0.2 |
GO:0042986 |
positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 0.0 |
0.0 |
GO:0021526 |
medial motor column neuron differentiation(GO:0021526) |
| 0.0 |
0.2 |
GO:0046498 |
S-adenosylhomocysteine metabolic process(GO:0046498) |
| 0.0 |
1.4 |
GO:1901385 |
regulation of voltage-gated calcium channel activity(GO:1901385) |
| 0.0 |
0.0 |
GO:1903748 |
negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
| 0.0 |
1.3 |
GO:0050919 |
negative chemotaxis(GO:0050919) |
| 0.0 |
0.3 |
GO:0089711 |
L-glutamate transmembrane transport(GO:0089711) |
| 0.0 |
0.0 |
GO:1903430 |
negative regulation of cell maturation(GO:1903430) |
| 0.0 |
0.1 |
GO:0021503 |
neural fold bending(GO:0021503) |
| 0.0 |
0.1 |
GO:0046340 |
diacylglycerol catabolic process(GO:0046340) |
| 0.0 |
0.2 |
GO:0060715 |
syncytiotrophoblast cell differentiation involved in labyrinthine layer development(GO:0060715) |
| 0.0 |
2.3 |
GO:0016266 |
O-glycan processing(GO:0016266) |
| 0.0 |
0.1 |
GO:0060023 |
soft palate development(GO:0060023) |
| 0.0 |
0.4 |
GO:0014717 |
regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
| 0.0 |
0.2 |
GO:0071468 |
cellular response to acidic pH(GO:0071468) |
| 0.0 |
0.1 |
GO:0045213 |
neurotransmitter receptor metabolic process(GO:0045213) |
| 0.0 |
0.2 |
GO:0060136 |
embryonic process involved in female pregnancy(GO:0060136) |
| 0.0 |
0.1 |
GO:0007341 |
penetration of zona pellucida(GO:0007341) |
| 0.0 |
0.2 |
GO:0035022 |
positive regulation of Rac protein signal transduction(GO:0035022) |
| 0.0 |
0.8 |
GO:0031122 |
cytoplasmic microtubule organization(GO:0031122) |
| 0.0 |
0.1 |
GO:0043321 |
regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
| 0.0 |
0.2 |
GO:0045204 |
MAPK export from nucleus(GO:0045204) |
| 0.0 |
0.0 |
GO:1990737 |
response to manganese-induced endoplasmic reticulum stress(GO:1990737) |
| 0.0 |
0.0 |
GO:0051389 |
inactivation of MAPKK activity(GO:0051389) |
| 0.0 |
0.3 |
GO:0000729 |
DNA double-strand break processing(GO:0000729) |
| 0.0 |
1.3 |
GO:0006270 |
DNA replication initiation(GO:0006270) |
| 0.0 |
0.1 |
GO:0072344 |
rescue of stalled ribosome(GO:0072344) |
| 0.0 |
0.1 |
GO:0060382 |
regulation of DNA strand elongation(GO:0060382) |
| 0.0 |
1.4 |
GO:0007190 |
activation of adenylate cyclase activity(GO:0007190) |
| 0.0 |
0.9 |
GO:0018196 |
peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
| 0.0 |
0.2 |
GO:0006449 |
regulation of translational termination(GO:0006449) |
| 0.0 |
0.1 |
GO:0050902 |
leukocyte adhesive activation(GO:0050902) |
| 0.0 |
0.2 |
GO:0050961 |
detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
| 0.0 |
0.2 |
GO:0045630 |
positive regulation of T-helper 2 cell differentiation(GO:0045630) |
| 0.0 |
1.5 |
GO:0042273 |
ribosomal large subunit biogenesis(GO:0042273) |
| 0.0 |
0.5 |
GO:0060297 |
regulation of sarcomere organization(GO:0060297) |
| 0.0 |
0.3 |
GO:0042026 |
protein refolding(GO:0042026) |
| 0.0 |
0.3 |
GO:0043569 |
negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.0 |
0.5 |
GO:0015868 |
purine ribonucleotide transport(GO:0015868) |
| 0.0 |
0.3 |
GO:0045910 |
negative regulation of DNA recombination(GO:0045910) |
| 0.0 |
0.6 |
GO:0051665 |
membrane raft localization(GO:0051665) |
| 0.0 |
0.3 |
GO:0021759 |
globus pallidus development(GO:0021759) |
| 0.0 |
0.1 |
GO:0030822 |
positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) |
| 0.0 |
0.0 |
GO:0070315 |
G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 0.0 |
0.3 |
GO:2001241 |
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.0 |
0.5 |
GO:0016973 |
poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.0 |
0.1 |
GO:0035733 |
hepatic stellate cell activation(GO:0035733) |
| 0.0 |
0.2 |
GO:0009134 |
nucleoside diphosphate catabolic process(GO:0009134) |
| 0.0 |
0.6 |
GO:0098534 |
centriole assembly(GO:0098534) |
| 0.0 |
0.1 |
GO:0038098 |
sequestering of BMP from receptor via BMP binding(GO:0038098) |
| 0.0 |
0.0 |
GO:0019401 |
glycerol biosynthetic process(GO:0006114) alditol biosynthetic process(GO:0019401) |
| 0.0 |
0.0 |
GO:0080009 |
mRNA methylation(GO:0080009) |
| 0.0 |
0.6 |
GO:0090004 |
positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
| 0.0 |
0.1 |
GO:1990022 |
RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.0 |
0.2 |
GO:0071285 |
cellular response to lithium ion(GO:0071285) |
| 0.0 |
0.1 |
GO:1903595 |
positive regulation of histamine secretion by mast cell(GO:1903595) |
| 0.0 |
0.2 |
GO:0007512 |
adult heart development(GO:0007512) |
| 0.0 |
0.1 |
GO:0034427 |
nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
| 0.0 |
0.4 |
GO:0032729 |
positive regulation of interferon-gamma production(GO:0032729) |
| 0.0 |
0.1 |
GO:0009048 |
dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.0 |
0.0 |
GO:0048630 |
skeletal muscle tissue growth(GO:0048630) regulation of skeletal muscle tissue growth(GO:0048631) |
| 0.0 |
0.3 |
GO:0071577 |
zinc II ion transmembrane transport(GO:0071577) |
| 0.0 |
0.2 |
GO:0001731 |
formation of translation preinitiation complex(GO:0001731) |
| 0.0 |
0.1 |
GO:0001967 |
suckling behavior(GO:0001967) |
| 0.0 |
0.1 |
GO:0042727 |
flavin-containing compound biosynthetic process(GO:0042727) |
| 0.0 |
0.2 |
GO:0010836 |
negative regulation of protein ADP-ribosylation(GO:0010836) |
| 0.0 |
0.2 |
GO:0042487 |
regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
| 0.0 |
1.4 |
GO:0001909 |
leukocyte mediated cytotoxicity(GO:0001909) |
| 0.0 |
1.0 |
GO:0030317 |
sperm motility(GO:0030317) |
| 0.0 |
0.3 |
GO:0071313 |
cellular response to caffeine(GO:0071313) |
| 0.0 |
0.3 |
GO:0035988 |
chondrocyte proliferation(GO:0035988) |
| 0.0 |
0.2 |
GO:0071600 |
otic vesicle morphogenesis(GO:0071600) |
| 0.0 |
0.4 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 0.0 |
0.1 |
GO:1901673 |
regulation of mitotic spindle assembly(GO:1901673) |
| 0.0 |
0.1 |
GO:0071460 |
cellular response to cell-matrix adhesion(GO:0071460) |
| 0.0 |
0.1 |
GO:0034421 |
post-translational protein acetylation(GO:0034421) |
| 0.0 |
0.2 |
GO:0032971 |
regulation of muscle filament sliding(GO:0032971) |
| 0.0 |
0.1 |
GO:0044256 |
angiotensin catabolic process in blood(GO:0002005) multicellular organismal protein catabolic process(GO:0044254) protein digestion(GO:0044256) multicellular organismal macromolecule catabolic process(GO:0044266) |
| 0.0 |
3.1 |
GO:0010923 |
negative regulation of phosphatase activity(GO:0010923) |
| 0.0 |
1.3 |
GO:0046513 |
ceramide biosynthetic process(GO:0046513) |
| 0.0 |
0.5 |
GO:0007176 |
negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
| 0.0 |
0.1 |
GO:2000254 |
regulation of male germ cell proliferation(GO:2000254) |
| 0.0 |
0.5 |
GO:0030262 |
apoptotic nuclear changes(GO:0030262) |
| 0.0 |
0.1 |
GO:0072656 |
maintenance of protein location in mitochondrion(GO:0072656) |
| 0.0 |
0.2 |
GO:1990035 |
calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
| 0.0 |
1.1 |
GO:0014047 |
glutamate secretion(GO:0014047) |
| 0.0 |
0.3 |
GO:0060123 |
regulation of growth hormone secretion(GO:0060123) |
| 0.0 |
0.1 |
GO:0007056 |
spindle assembly involved in female meiosis(GO:0007056) |
| 0.0 |
0.2 |
GO:0006931 |
substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.0 |
0.2 |
GO:0021578 |
hindbrain maturation(GO:0021578) central nervous system maturation(GO:0021626) |
| 0.0 |
0.3 |
GO:0015671 |
oxygen transport(GO:0015671) |
| 0.0 |
0.0 |
GO:0048846 |
axon extension involved in axon guidance(GO:0048846) neuron projection extension involved in neuron projection guidance(GO:1902284) |
| 0.0 |
1.1 |
GO:0007189 |
adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
| 0.0 |
0.0 |
GO:0044333 |
Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
| 0.0 |
0.0 |
GO:0022605 |
oogenesis stage(GO:0022605) |
| 0.0 |
0.1 |
GO:0045357 |
interferon-beta biosynthetic process(GO:0045350) regulation of interferon-beta biosynthetic process(GO:0045357) |
| 0.0 |
0.1 |
GO:0038161 |
prolactin signaling pathway(GO:0038161) |
| 0.0 |
1.8 |
GO:0007218 |
neuropeptide signaling pathway(GO:0007218) |
| 0.0 |
0.1 |
GO:2000852 |
regulation of corticosterone secretion(GO:2000852) |
| 0.0 |
0.2 |
GO:0002566 |
somatic diversification of immune receptors via somatic mutation(GO:0002566) |
| 0.0 |
1.5 |
GO:0048791 |
calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.0 |
0.1 |
GO:0072674 |
multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
| 0.0 |
0.2 |
GO:0000712 |
resolution of meiotic recombination intermediates(GO:0000712) meiotic chromosome separation(GO:0051307) |
| 0.0 |
0.1 |
GO:0046013 |
T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
| 0.0 |
0.1 |
GO:0006882 |
cellular zinc ion homeostasis(GO:0006882) |
| 0.0 |
0.7 |
GO:0007223 |
Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
| 0.0 |
0.6 |
GO:2000821 |
regulation of grooming behavior(GO:2000821) |
| 0.0 |
0.0 |
GO:2000807 |
regulation of synaptic vesicle clustering(GO:2000807) |
| 0.0 |
0.1 |
GO:0060133 |
somatotropin secreting cell development(GO:0060133) |
| 0.0 |
0.0 |
GO:0031125 |
rRNA 3'-end processing(GO:0031125) |
| 0.0 |
0.2 |
GO:0010886 |
positive regulation of cholesterol storage(GO:0010886) |
| 0.0 |
0.1 |
GO:0072531 |
pyrimidine-containing compound transmembrane transport(GO:0072531) |
| 0.0 |
0.1 |
GO:0002024 |
diet induced thermogenesis(GO:0002024) |
| 0.0 |
0.3 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 0.0 |
0.1 |
GO:0051383 |
kinetochore organization(GO:0051383) |
| 0.0 |
0.3 |
GO:0006491 |
N-glycan processing(GO:0006491) |
| 0.0 |
0.0 |
GO:0033484 |
nitric oxide homeostasis(GO:0033484) |
| 0.0 |
0.6 |
GO:0007202 |
activation of phospholipase C activity(GO:0007202) |
| 0.0 |
0.2 |
GO:0090084 |
negative regulation of inclusion body assembly(GO:0090084) |
| 0.0 |
0.1 |
GO:0046952 |
ketone body catabolic process(GO:0046952) |
| 0.0 |
0.0 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) |
| 0.0 |
0.0 |
GO:0071352 |
cellular response to interleukin-2(GO:0071352) |
| 0.0 |
1.0 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.0 |
0.0 |
GO:0001757 |
somite specification(GO:0001757) |
| 0.0 |
3.4 |
GO:0050907 |
detection of chemical stimulus involved in sensory perception(GO:0050907) detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
| 0.0 |
0.1 |
GO:0006883 |
cellular sodium ion homeostasis(GO:0006883) |
| 0.0 |
0.0 |
GO:0032472 |
Golgi calcium ion transport(GO:0032472) |
| 0.0 |
0.1 |
GO:0098507 |
polynucleotide 5' dephosphorylation(GO:0098507) |
| 0.0 |
0.0 |
GO:0009227 |
nucleotide-sugar catabolic process(GO:0009227) |
| 0.0 |
0.0 |
GO:0051037 |
regulation of transcription involved in meiotic cell cycle(GO:0051037) |
| 0.0 |
0.0 |
GO:0009726 |
detection of endogenous stimulus(GO:0009726) |
| 0.0 |
0.2 |
GO:0021527 |
spinal cord association neuron differentiation(GO:0021527) |
| 0.0 |
0.1 |
GO:1903078 |
positive regulation of protein localization to plasma membrane(GO:1903078) |
| 0.0 |
0.2 |
GO:0045066 |
regulatory T cell differentiation(GO:0045066) |
| 0.0 |
0.1 |
GO:0046040 |
IMP metabolic process(GO:0046040) |
| 0.0 |
0.1 |
GO:0008612 |
peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.0 |
0.3 |
GO:0061157 |
mRNA destabilization(GO:0061157) |
| 0.0 |
0.0 |
GO:0072114 |
regulation of pronephros size(GO:0035565) pronephros morphogenesis(GO:0072114) |
| 0.0 |
2.2 |
GO:0007156 |
homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.0 |
0.1 |
GO:0019355 |
nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.0 |
0.4 |
GO:0097320 |
membrane tubulation(GO:0097320) |
| 0.0 |
0.1 |
GO:0000012 |
single strand break repair(GO:0000012) |
| 0.0 |
0.0 |
GO:0034146 |
toll-like receptor 5 signaling pathway(GO:0034146) |
| 0.0 |
0.2 |
GO:0006032 |
chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 0.0 |
0.1 |
GO:0036438 |
maintenance of lens transparency(GO:0036438) |
| 0.0 |
0.3 |
GO:0050716 |
positive regulation of interleukin-1 secretion(GO:0050716) |
| 0.0 |
0.1 |
GO:0006528 |
asparagine metabolic process(GO:0006528) |
| 0.0 |
0.3 |
GO:0007597 |
blood coagulation, intrinsic pathway(GO:0007597) |
| 0.0 |
0.0 |
GO:0007343 |
egg activation(GO:0007343) |
| 0.0 |
0.1 |
GO:0035617 |
stress granule disassembly(GO:0035617) |
| 0.0 |
0.1 |
GO:0036507 |
protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) |
| 0.0 |
0.0 |
GO:0003415 |
chondrocyte hypertrophy(GO:0003415) |
| 0.0 |
0.2 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
| 0.0 |
0.1 |
GO:2000857 |
positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
| 0.0 |
0.1 |
GO:0052651 |
monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
| 0.0 |
0.2 |
GO:0043252 |
sodium-independent organic anion transport(GO:0043252) |
| 0.0 |
0.1 |
GO:0000066 |
mitochondrial ornithine transport(GO:0000066) |
| 0.0 |
0.2 |
GO:0035721 |
intraciliary retrograde transport(GO:0035721) |
| 0.0 |
0.1 |
GO:0050901 |
leukocyte tethering or rolling(GO:0050901) |
| 0.0 |
0.0 |
GO:0086067 |
AV node cell to bundle of His cell communication(GO:0086067) |
| 0.0 |
0.0 |
GO:0060054 |
positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
| 0.0 |
0.2 |
GO:0007638 |
mechanosensory behavior(GO:0007638) |
| 0.0 |
0.1 |
GO:0060746 |
maternal behavior(GO:0042711) parental behavior(GO:0060746) |
| 0.0 |
0.0 |
GO:0006862 |
nucleotide transport(GO:0006862) |
| 0.0 |
0.0 |
GO:0048686 |
modulation by virus of host transcription(GO:0019056) regulation of sprouting of injured axon(GO:0048686) positive regulation of sprouting of injured axon(GO:0048687) regulation of axon extension involved in regeneration(GO:0048690) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
| 0.0 |
0.0 |
GO:0061034 |
olfactory bulb mitral cell layer development(GO:0061034) |
| 0.0 |
0.1 |
GO:0051923 |
sulfation(GO:0051923) |
| 0.0 |
0.0 |
GO:0051793 |
medium-chain fatty acid catabolic process(GO:0051793) |
| 0.0 |
0.0 |
GO:0001975 |
response to amphetamine(GO:0001975) |
| 0.0 |
0.0 |
GO:0014807 |
regulation of somitogenesis(GO:0014807) |
| 0.0 |
0.1 |
GO:0070816 |
phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.0 |
0.1 |
GO:0018023 |
peptidyl-lysine trimethylation(GO:0018023) |
| 0.0 |
0.0 |
GO:0045408 |
regulation of interleukin-6 biosynthetic process(GO:0045408) |
